GT,Diagnosis 1,ERN Category
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia: Symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. Key symptoms not reported include developmental delays and failure to thrive. 
+2 Propionic Acidemia: Symptoms include metabolic acidosis and can lead to similar outcomes. Key symptoms not reported include hypoglycemia and specific neurological symptoms. 
+3 Isovaleric Acidemia: Symptoms include metabolic acidosis and can present similarly. Key symptoms not reported include distinctive body odor and acute metabolic crises. 
+4 Maple Syrup Urine Disease: Symptoms include metabolic acidosis and neurological decline. Key symptoms not reported include characteristic sweet-smelling urine and maple syrup odor. 
+5 Glutaric Acidemia: Symptoms include metabolic acidosis and neurological symptoms. Key symptoms not reported include movement disorders and macrocephaly.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Organic Acidemia: This diagnosis is supported by elevated urinary carboxylic acid levels, motor delay, and hypotonia. Key symptoms not reported include metabolic crises or acidosis episodes.
+2 Mitochondrial Disorder: This condition aligns with hypotonia, motor delay, and potential respiratory issues leading to pneumonia. Key symptoms not reported may include exercise intolerance or seizures.
+3 Spinal Muscular Atrophy (SMA): Characterized by motor delay and generalized hypotonia. Key symptoms not reported include progressive muscle weakness and atrophy.
+4 Congenital Myopathy: Fits with hypotonia and motor delay. Key symptoms not reported include muscle weakness and potential respiratory complications.
+5 Metabolic Myopathy: Could explain hypotonia and motor delay. Key symptoms not reported include exercise intolerance and muscle pain after exertion.",Hereditary metabolic disorders
['Phenylketonuria'],"<thinking> 
The patient presents with a combination of symptoms that suggest a serious underlying metabolic disorder or congenital condition. Key symptoms include:

1. **Abnormality of prenatal development or birth**: This indicates that there may have been issues during gestation that could lead to congenital anomalies.
2. **Death in infancy**: This is a critical symptom that suggests a severe condition that could lead to early mortality.
3. **Hypertyrosinemia**: This is a metabolic disorder characterized by elevated levels of tyrosine in the blood, often due to a deficiency in the enzyme fumarylacetoacetate hydrolase.
4. **Neonatal death**: Similar to the previous symptom, this reinforces the severity of the condition, indicating that the infant did not survive past the neonatal period.
5. **Hyperphenylalaninemia**: This condition is characterized by elevated phenylalanine levels, often associated with phenylketonuria (PKU), which can lead to intellectual disability if untreated.

Given these symptoms, several potential diagnoses come to mind:

- **Tyrosinemia Type I**: This condition is characterized by hypertyrosinemia and can lead to severe liver dysfunction, renal tubular dysfunction, and neurological issues. The presence of neonatal death aligns with the severe outcomes associated with untreated tyrosinemia.
  
- **Phenylketonuria (PKU)**: Hyperphenylalaninemia is a hallmark of PKU, which can lead to severe intellectual disability if not managed. However, the combination of symptoms suggests a more complex metabolic disorder rather than isolated PKU.

- **Maple Syrup Urine Disease (MSUD)**: This condition can present with elevated levels of branched-chain amino acids and can lead to severe neurological impairment and death in infancy. However, the specific mention of hypertyrosinemia and hyperphenylalaninemia makes this less likely.

- **Galactosemia**: This metabolic disorder can lead to failure to thrive and can be fatal if not treated. However, it does not typically present with hypertyrosinemia or hyperphenylalaninemia.

- **Congenital Disorders of Glycosylation**: These can present with a variety of symptoms, including developmental abnormalities and metabolic disturbances, but the specific combination of symptoms here is more indicative of the previously mentioned conditions.

To narrow down the diagnosis, additional tests could include:

- Genetic testing to identify specific mutations associated with tyrosinemia or PKU.
- Blood tests to measure levels of tyrosine and phenylalanine.
- Liver function tests to assess any hepatic involvement.
- Newborn screening tests to check for metabolic disorders.

Overall, the combination of symptoms suggests a severe metabolic disorder that requires immediate attention and further investigation. 
</thinking>

<top5> 
+1 Tyrosinemia Type I: This condition is consistent with hypertyrosinemia and can lead to neonatal death. Key symptoms not reported include liver dysfunction and renal issues. 
+2 Phenylketonuria (PKU): Hyperphenylalaninemia aligns with this diagnosis, but the severity of other symptoms suggests a more complex condition. Key symptoms not reported include developmental delays if untreated. 
+3 Maple Syrup Urine Disease (MSUD): While it can lead to neonatal death, the specific metabolic markers do not align as closely with the reported symptoms. Key symptoms not reported include sweet-smelling urine and neurological symptoms. 
+4 Galactosemia: This condition can cause severe complications in infancy, but it does not typically present with the specific amino acid abnormalities noted. Key symptoms not reported include jaundice and failure to thrive. 
+5 Congenital Disorders of Glycosylation: These can present with developmental abnormalities, but the specific combination of symptoms is more indicative of tyrosinemia or PKU. Key symptoms not reported include multi-organ involvement and developmental delays. 
</top5",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Congenital Muscular Dystrophy: Symptoms consistent with this diagnosis include motor delay and failure to thrive. Key symptoms not reported include muscle weakness and joint contractures. 
+2 Bardet-Biedl Syndrome: Symptoms consistent with this diagnosis include motor delay, failure to thrive, and potential lipodystrophy. Key symptoms not reported include retinal dystrophy and polydactyly. 
+3 Dandy-Walker Malformation: Symptoms consistent with this diagnosis include cerebellar atrophy and motor delay. Key symptoms not reported include hydrocephalus and developmental delays. 
+4 Congenital Diaphragmatic Hernia Syndrome: Symptoms consistent with this diagnosis include congenital diaphragmatic hernia and failure to thrive. Key symptoms not reported include respiratory distress and pulmonary hypoplasia. 
+5 Cerebellar Agenesis: Symptoms consistent with this diagnosis include cerebellar agenesis and motor delay. Key symptoms not reported include ataxia and developmental delays.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, and neurological impairment. Key symptoms not reported include characteristic sweet-smelling urine.

+2 Urea Cycle Disorders: Symptoms consistent include elevated amino acids, hypotonia, and developmental delays. Key symptoms not reported include hyperammonemia and specific neurological crises.

+3 Congenital Disorders of Glycosylation (CDG): Symptoms consistent include developmental delays, hypotonia, and systemic issues. Key symptoms not reported include specific dysmorphic features or organ dysfunction.

+4 Neurodegenerative Disorders: Symptoms consistent include hypotonia, motor delays, and early mortality. Key symptoms not reported include progressive weakness or specific neurological signs.

+5 Mitochondrial Disorders: Symptoms consistent include developmental delays, hypotonia, and organ dysfunction. Key symptoms not reported include exercise intolerance or specific metabolic crises.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Genetic Syndrome: Prader-Willi Syndrome: This condition is characterized by obesity, skin abnormalities, and developmental issues. The patient's obesity and skin rash align with this diagnosis. Key symptoms not reported include hypogonadism and behavioral problems. 

+2 Metabolic Disorder: Tyrosinemia: The presence of hypertyrosinemia suggests this condition, which can lead to liver dysfunction and gastrointestinal symptoms. The patient's diarrhea and gastrointestinal inflammation are consistent with this diagnosis. Key symptoms not reported include liver failure and neurological issues.

+3 Immunodeficiency Disorder: Severe Combined Immunodeficiency (SCID): The recurrent viral infections and neonatal death could indicate an underlying immunodeficiency. This condition often presents with failure to thrive and severe infections. Key symptoms not reported include absence of lymphoid tissue and chronic diarrhea.

+4 Genetic Disorder: Phenylketonuria (PKU): The presence of hyperphenylalaninemia aligns with this diagnosis, which can lead to developmental delays and skin issues. The patient's skin rash may be related to dietary factors. Key symptoms not reported include intellectual disability and seizures.

+5 Congenital Disorder: Congenital Cytomegalovirus Infection: This condition can lead to a range of symptoms including skin rashes, developmental delays, and gastrointestinal issues. The patient's combination of symptoms, including neonatal death and recurrent infections, supports this diagnosis. Key symptoms not reported include hearing loss and microcephaly.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Mitochondrial disorder: Increased circulating lactate concentration, increased CSF lactate, eczematoid dermatitis. Key symptoms not reported: Neurological deficits, muscle weakness. 
+2 Barth syndrome: Alopecia, increased lactate levels, eczematoid dermatitis. Key symptoms not reported: Cardiomyopathy, neutropenia. 
+3 Organic acidemia: Increased circulating lactate concentration, skin rash. Key symptoms not reported: Vomiting, developmental delays. 
+4 Autoimmune condition (e.g., lupus erythematosus): Skin rash, alopecia. Key symptoms not reported: Joint pain, systemic symptoms (fever, fatigue). 
+5 Atopic dermatitis: Skin rash, eczematoid dermatitis. Key symptoms not reported: Itching, family history of atopy.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Genetic Syndrome (e.g., Bardet-Biedl Syndrome): Symptoms consistent include rod-cone dystrophy, intellectual disability, abnormal facial shape, and possible lipodystrophy. Key symptoms not reported may include obesity and renal anomalies. 
+2 Metabolic Disorder (e.g., Alström Syndrome): Symptoms consistent include rod-cone dystrophy, intellectual disability, and lipodystrophy. Key symptoms not reported may include cardiomyopathy and hearing loss. 
+3 Cerebellar Dysgenesis Syndrome: Symptoms consistent include cerebellar atrophy and agenesis, intellectual disability, and abnormal facial shape. Key symptoms not reported may include seizures and developmental delays. 
+4 Thrombotic Thrombocytopenic Purpura (TTP): Symptoms consistent include thromboembolism and possible liver dysfunction. Key symptoms not reported may include microangiopathic hemolytic anemia and neurological symptoms. 
+5 Mitochondrial Disorder (e.g., Alpers-Huttenlocher Syndrome): Symptoms consistent include intellectual disability, liver dysfunction (acute and chronic hepatitis), and neurological symptoms (cerebellar atrophy). Key symptoms not reported may include seizures and developmental regression.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric aciduria type I: This condition is consistent with the patient's symptoms of dystonia, hypotonia, and lethargy. Key symptoms not reported include episodes of metabolic crisis or acute neurological deterioration.
+2 Primary carnitine deficiency: The decreased plasma free carnitine aligns with this diagnosis, along with lethargy and hypotonia. Key symptoms not reported include muscle weakness and cardiomyopathy.
+3 Congenital infections (e.g., cytomegalovirus): Macrocephaly and lethargy are consistent with this diagnosis. Key symptoms not reported include hearing loss and microcephaly.
+4 Turner syndrome: The cystic hygroma and macrocephaly suggest this diagnosis. Key symptoms not reported include short stature and ovarian dysgenesis.
+5 Mitochondrial disorder: The combination of neurological symptoms and metabolic derangements could fit this diagnosis. Key symptoms not reported include exercise intolerance and seizures.",Hereditary metabolic disorders
['Isovaleric acidemia'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, lethargy, drowsiness, and feeding difficulties. Key symptoms not reported include vomiting and irritability. 
+2 Non-Ketotic Hyperglycinemia: Symptoms consistent include lethargy, drowsiness, and feeding difficulties. Key symptoms not reported include seizures and hypotonia. 
+3 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): Symptoms consistent include lethargy, feeding difficulties, and potential for hyperammonemia. Key symptoms not reported include hypoglycemia and metabolic crises. 
+4 Organic Acidemia: Symptoms consistent include lethargy, feeding difficulties, and abnormal metabolic markers. Key symptoms not reported include acidosis and vomiting. 
+5 Carnitine Transport Deficiency: Symptoms consistent include abnormal carnitine concentration, lethargy, and feeding difficulties. Key symptoms not reported include muscle weakness and cardiomyopathy.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Cerebellar malformations: Symptoms consistent include cerebellar agenesis, ataxia, and hypotonia. Key symptoms not reported may include specific motor coordination issues.
+2 Genetic syndromes: Symptoms consistent include microcephaly, intellectual disability, and growth delay. Key symptoms not reported may include specific facial dysmorphisms or other systemic features.
+3 Metabolic disorders: Symptoms consistent include encephalopathy and developmental delays. Key symptoms not reported may include specific metabolic crisis episodes or unusual biochemical markers.
+4 Congenital infections: Symptoms consistent include microcephaly and neurological deficits. Key symptoms not reported may include signs of infection during pregnancy or other systemic symptoms.
+5 Neurodegenerative disorders: Symptoms consistent include intellectual disability and motor delays. Key symptoms not reported may include progressive symptoms or specific age-related decline in function.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, motor delay, and hypotonia. Key symptoms not reported include acute neurological crises or lethargy. 
+2 Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid and methylmalonic aciduria, along with developmental delays. Key symptoms not reported include metabolic acidosis or episodic vomiting. 
+3 Mitochondrial Disorder: Symptoms consistent include optic atrophy, hypotonia, and developmental delays. Key symptoms not reported include exercise intolerance or seizures. 
+4 Congenital Metabolic Disorder: Symptoms consistent include abnormal circulating carnitine concentration and motor delay. Key symptoms not reported include hypoglycemia or cardiomyopathy. 
+5 Chromosomal Abnormality or Syndrome: Symptoms consistent include strabismus, nystagmus, and congenital heart defect. Key symptoms not reported include dysmorphic features or specific developmental milestones.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Fatty Acid Oxidation Disorder: Symptoms include hypoglycemia, vomiting, diarrhea, elevated hepatic transaminases, and abnormal carnitine levels. Key symptoms not reported may include muscle weakness or cardiomyopathy.
+2 Urea Cycle Disorder: Symptoms can include elevated transaminases and metabolic crises, but hypoglycemia and diarrhea are less common. Key symptoms not reported may include hyperammonemia.
+3 Glycogen Storage Disease: Symptoms include hypoglycemia and liver dysfunction, but diarrhea and vomiting are less typical. Key symptoms not reported may include hepatomegaly.
+4 Organic Acidemia: Symptoms can include metabolic crises and elevated transaminases, but the specific combination of symptoms leans more towards fatty acid oxidation disorders. Key symptoms not reported may include metabolic acidosis.
+5 Mitochondrial Disorder: Symptoms can include metabolic crises and liver dysfunction, but the specific findings of elevated transaminases and abnormal carnitine levels are more indicative of a fatty acid oxidation issue. Key symptoms not reported may include neurological symptoms or exercise intolerance.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Congenital adrenal hyperplasia (CAH): Coma, hyperkalemia, hyponatremia, respiratory acidosis. Key symptoms not reported: Ambiguous genitalia, adrenal crisis symptoms. 
+2 Urea cycle disorders: Coma, elevated urinary carboxylic acid, respiratory acidosis. Key symptoms not reported: Hyperammonemia, vomiting, lethargy. 
+3 Mitochondrial disorders: Coma, respiratory acidosis, elevated urinary carboxylic acid. Key symptoms not reported: Muscle weakness, developmental delays. 
+4 Severe renal tubular acidosis: Hyperkalemia, hyponatremia, respiratory acidosis. Key symptoms not reported: Growth failure, bone disease. 
+5 Organic acidemias: Coma, elevated urinary carboxylic acid, respiratory acidosis. Key symptoms not reported: Metabolic crises, feeding difficulties.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Marfan syndrome: Symptoms consistent include ectopia lentis, large hands, and long foot. Key symptoms not reported include tall stature and cardiovascular issues. 
+2 Homocystinuria: Symptoms consistent include intellectual disability, motor delay, hyperhomocystinemia, and ectopia lentis. Key symptoms not reported include seizures and thromboembolic events. 
+3 Ehlers-Danlos syndrome: Symptoms consistent include large hands and possible motor delay. Key symptoms not reported include skin hyperelasticity and joint hypermobility. 
+4 Klinefelter syndrome: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported include hypogonadism and gynecomastia. 
+5 Wilson's disease: Symptoms consistent include fatigue and possible neurological symptoms. Key symptoms not reported include liver dysfunction and Kayser-Fleischer rings.",Hereditary metabolic disorders
[],"+1 Prader-Willi Syndrome: This condition is characterized by hypotonia, feeding difficulties, hyperphagia, and developmental delays. The wide mouth and epicanthus are consistent with this diagnosis, but the presence of seizures and early death is less typical. 
+2 Congenital Hyperinsulinism: This condition leads to excessive insulin production, resulting in hypoglycemia. The symptoms of hyperinsulinemia and hypoglycemia align well, but the other features (like wide mouth and epicanthus) are not typical. 
+3 Glycogen Storage Disease: This group of disorders can cause hypoglycemia and feeding difficulties, along with potential neurological issues. The abnormal hemoglobin could suggest a related metabolic issue, but the specific facial features are not characteristic. 
+4 Hemoglobinopathies (e.g., Sickle Cell Disease): The abnormal hemoglobin and potential for severe complications align with this diagnosis. However, the other symptoms, particularly the wide mouth and seizures, are not typical for this condition. 
+5 Mucopolysaccharidosis: This group of lysosomal storage disorders can present with facial dysmorphisms (like wide mouth and epicanthus), feeding difficulties, and neurological symptoms. The history of early death and seizures fits, but hyperinsulinemia is not a common feature.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: This could explain hyperammonemia, seizures, and intellectual disability. Key symptoms not reported include specific metabolic crisis episodes. 
+2 Non-ketotic Hyperglycinemia: Fits with hyperglycinemia, seizures, and motor delay. Key symptoms not reported include specific neurological deficits or abnormal EEG findings. 
+3 Organic Acidemia: Could account for metabolic derangements and neurological symptoms. Key symptoms not reported include specific metabolic acidosis or ketotic episodes. 
+4 Carnitine Transport Defect: Aligns with abnormal carnitine levels and neurological symptoms. Key symptoms not reported include specific muscle weakness or cardiomyopathy. 
+5 Mitochondrial Disorder: Explains developmental delays, seizures, and metabolic issues. Key symptoms not reported include exercise intolerance or specific organ involvement.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia (MMA): Symptoms include generalized hypotonia, metabolic acidosis, feeding difficulties, and methylmalonic aciduria. Key symptoms not reported include developmental delays and potential neurological deficits.
+2 Propionic acidemia: Symptoms include metabolic acidosis, hypotonia, and feeding difficulties. Key symptoms not reported include ketonuria and specific metabolic derangements.
+3 Organic acidemia: General category that includes MMA and propionic acidemia. Symptoms include metabolic acidosis and hypotonia. Key symptoms not reported vary widely depending on the specific type.
+4 Urea cycle disorder: Symptoms can include metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and specific neurological deficits.
+5 Fatty acid oxidation disorder: Symptoms can include metabolic acidosis and hypotonia. Key symptoms not reported include hypoglycemia and specific metabolic derangements.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"+1 Urea Cycle Disorder: Symptoms consistent include coma, vomiting, and potential metabolic derangements. Key symptoms not reported include elevated ammonia levels.
+2 Fatty Acid Oxidation Disorder: Symptoms consistent include hypoglycemia and coma. Key symptoms not reported include specific acylcarnitine profiles.
+3 Mitochondrial Disorder: Symptoms consistent include coma, vomiting, and increased lactate dehydrogenase. Key symptoms not reported include exercise intolerance or myopathy.
+4 Organic Acidemia: Symptoms consistent include hypoglycemia and vomiting. Key symptoms not reported include specific organic acid elevations in urine.
+5 Liver Disease: Symptoms consistent include elevated alkaline phosphatase and potential metabolic derangements. Key symptoms not reported include jaundice or abdominal pain.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1 Primary Carnitine Deficiency: Symptoms include lethargy, poor coordination, and feeding difficulties. Key symptoms not reported include muscle weakness and hypoglycemia. 
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Symptoms include lethargy, clumsiness, and feeding difficulties. Key symptoms not reported include hypoglycemia and episodes of metabolic crisis. 
+3 Mitochondrial Myopathy: Symptoms include lethargy and poor coordination. Key symptoms not reported include muscle pain and exercise intolerance. 
+4 Urea Cycle Disorder: Symptoms include lethargy and feeding difficulties. Key symptoms not reported include vomiting and altered mental status. 
+5 Organic Acidemia: Symptoms include lethargy and poor feeding. Key symptoms not reported include metabolic acidosis and developmental delays.",Hereditary metabolic disorders
[],"+1 Mitochondrial Myopathy: Symptoms include spastic diplegia, dysarthria, and encephalopathy. Key symptoms not reported may include muscle weakness and exercise intolerance. 
+2 Glycine Encephalopathy: Characterized by abnormal glycine levels and neurological symptoms such as delayed speech and spasticity. Key symptoms not reported may include seizures and hypotonia. 
+3 Ethylmalonic Aciduria: Associated with metabolic disturbances, recurrent infections, and neurological symptoms. Key symptoms not reported may include failure to thrive and developmental regression. 
+4 Spastic Quadriplegia: Fits with spastic diplegia and hyperreflexia. Key symptoms not reported may include significant motor impairment and potential cognitive delays. 
+5 Mitochondrial Encephalomyopathy: Encompasses a range of symptoms including encephalopathy, spasticity, and metabolic issues. Key symptoms not reported may include lactic acidosis and exercise intolerance.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase I Deficiency: This condition is consistent with the abnormal circulating carnitine concentration and can lead to death in infancy. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness.

+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): The abnormal carnitine levels align with this diagnosis, which can also result in neonatal death. Key symptoms not reported include episodes of hypoglycemia and lethargy.

+3 Congenital Heart Defects: This could explain the death in infancy and abnormal prenatal development. Key symptoms not reported include cyanosis or heart murmurs.

+4 Mitochondrial Disorders: The combination of symptoms suggests a possible mitochondrial dysfunction. Key symptoms not reported include developmental delays and organ dysfunction.

+5 Genetic Syndromes (e.g., Zellweger Spectrum Disorders): These can lead to severe developmental issues and early mortality. Key symptoms not reported include hypotonia and facial dysmorphism.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms consistent include elevated circulating glutaric acid concentration, metabolic acidosis, generalized hypotonia, and dystonia. Key symptoms not reported include specific neurological regression or movement disorders typical in later stages.
+2 Congenital Disorders of Glycosylation: Symptoms consistent include macrocephaly, lethargy, and hypotonia. Key symptoms not reported include specific dysmorphic features or organ dysfunction.
+3 Mitochondrial Disorders: Symptoms consistent include lethargy, hypotonia, and metabolic acidosis. Key symptoms not reported include specific myopathy or exercise intolerance.
+4 Neurodegenerative Disorders: Symptoms consistent include lethargy and hypotonia. Key symptoms not reported include progressive neurological decline or seizures.
+5 Genetic Syndromes (e.g., Turner Syndrome): Symptoms consistent include cystic hygroma and macrocephaly. Key symptoms not reported include short stature or other dysmorphic features.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include Hyperphenylalaninemia. Key symptoms not reported include developmental delays or neurological symptoms. 
+2 Tyrosinemia: Symptoms consistent include Hypertyrosinemia. Key symptoms not reported include liver dysfunction or renal issues. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include metabolic disorder context. Key symptoms not reported include sweet-smelling urine or neurological symptoms. 
+4 Urea Cycle Disorders: Symptoms consistent include metabolic disorder context. Key symptoms not reported include hyperammonemia or specific neurological symptoms. 
+5 Congenital Disorders of Glycosylation: Symptoms consistent include Abnormality of prenatal development or birth. Key symptoms not reported include specific glycosylation-related symptoms.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1: Leukodystrophy: Symptoms consistent include abnormal cerebral white matter morphology, intellectual disability, and motor difficulties. Key symptoms not reported may include seizures or progressive neurological decline.
+2: Pelizaeus-Merzbacher disease: Symptoms consistent include delayed speech and language development, intellectual disability, hyperreflexia, and abnormal white matter morphology. Key symptoms not reported may include nystagmus or ataxia.
+3: Krabbe disease: Symptoms consistent include intellectual disability, hyperreflexia, and motor difficulties. Key symptoms not reported may include irritability or loss of previously acquired skills.
+4: Cerebral palsy: Symptoms consistent include difficulty walking, climbing stairs, and running, along with developmental delays. Key symptoms not reported may include spasticity or abnormal muscle tone.
+5: Chromosomal abnormality (e.g., Down syndrome): Symptoms consistent include intellectual disability and developmental delays. Key symptoms not reported may include characteristic facial features or congenital heart defects.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hypervalinemia, hyperleucinemia, hyperisoleucinemia, spasticity, and hypotonia. Key symptoms not reported include neurological decline or developmental delays in early childhood. 
+2 Urea Cycle Disorder: Symptoms consistent include hypotonia and metabolic derangements. Key symptoms not reported include hyperammonemia and associated neurological symptoms. 
+3 Prader-Willi Syndrome: Symptoms consistent include obesity and hypotonia. Key symptoms not reported include hypogonadism and behavioral issues. 
+4 Spinal Muscular Atrophy (SMA): Symptoms consistent include generalized hypotonia and spasticity. Key symptoms not reported include progressive muscle weakness and atrophy. 
+5 Mitochondrial Disorder: Symptoms consistent include apathy and hypotonia. Key symptoms not reported include exercise intolerance and multi-system involvement.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: This condition is consistent with hypergalactosemia, increased total bilirubin, and developmental delays. Key symptoms not reported include cataracts and liver dysfunction.
+2 Maple Syrup Urine Disease: This could explain the aminoaciduria and developmental delays. Key symptoms not reported include a characteristic sweet odor in urine and acute metabolic crises.
+3 Tyrosinemia: This condition aligns with abnormal circulating tyrosine concentration and could lead to developmental delays. Key symptoms not reported include liver failure and renal issues.
+4 Urea Cycle Disorder: This could explain hyperalaninemia and developmental delays. Key symptoms not reported include hyperammonemia and acute neurological symptoms.
+5 Fatty Acid Oxidation Disorder: This could lead to metabolic derangements and developmental issues. Key symptoms not reported include hypoglycemia and muscle weakness.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1: Organic acidemia (3-methylglutaconic aciduria): Symptoms include metabolic acidosis, hyperammonemia, and 3-methylglutaric aciduria. Key symptoms not reported include neurological deficits.
+2: Propionic acidemia: Symptoms include metabolic acidosis, hyperammonemia, and dicarboxylic aciduria. Key symptoms not reported include hypoglycemia and potential cardiomyopathy.
+3: Urea cycle disorder (Ornithine transcarbamylase deficiency): Symptoms include hyperammonemia and metabolic acidosis. Key symptoms not reported include neurological symptoms and specific amino acid imbalances.
+4: Glycine encephalopathy (non-ketotic hyperglycinemia): Symptoms include elevated glycine and metabolic disturbances. Key symptoms not reported include seizures and developmental delays.
+5: Isovaleric acidemia: Symptoms include metabolic acidosis and vomiting. Key symptoms not reported include a characteristic odor (sweaty feet) and potential for acute metabolic crises.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: This condition is consistent with hyperhomocystinemia and hypomethioninemia. Key symptoms not reported include lens dislocation and skeletal abnormalities. 
+2 Methionine adenosyltransferase deficiency: The patient's hypomethioninemia and neurological symptoms align with this diagnosis. Key symptoms not reported include liver dysfunction and developmental delays. 
+3 Porphyria: The abnormal circulating porphyrin concentration suggests this condition. Key symptoms not reported include photosensitivity and abdominal pain. 
+4 Urea cycle disorder: The combination of jaundice, hypotonia, and neurological deterioration could suggest this disorder. Key symptoms not reported include hyperammonemia and respiratory distress. 
+5 Combined immunodeficiency: The recurrent viral infections and neurological deterioration suggest this condition. Key symptoms not reported include failure to thrive and recurrent bacterial infections.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia. Key symptoms not reported include neurological impairment or developmental delays. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia. Key symptoms not reported include liver dysfunction or renal issues. 
+3 Congenital Heart Disease: Symptoms consistent include upper airway obstruction and chronic pulmonary obstruction. Key symptoms not reported include specific cardiac symptoms or findings. 
+4 Congenital Anomalies: Symptoms consistent include abnormality of prenatal development or birth. Key symptoms not reported include specific physical anomalies or syndromic features. 
+5 Metabolic Syndrome: Symptoms consistent include metabolic disorders leading to early mortality. Key symptoms not reported include specific metabolic dysfunctions or syndromic features.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic Acidemia: This diagnosis aligns with the elevated urinary carboxylic acid and neurological symptoms. Key symptoms not reported include metabolic acidosis and specific dietary intolerances. 
+2 Urea Cycle Disorder: This could explain the neurological symptoms and elevated urinary metabolites, but typically presents with hyperammonemia. Key symptoms not reported include vomiting and lethargy during metabolic crises. 
+3 Leigh Syndrome: Fits the neurological symptoms and early death, but would typically show more pronounced metabolic derangements. Key symptoms not reported include developmental delays and respiratory distress. 
+4 Krabbe Disease: Matches with spasticity and seizures leading to early death, but does not typically show elevated urinary carboxylic acid. Key symptoms not reported include peripheral neuropathy and vision loss. 
+5 Amino Acid Metabolism Disorder: Could explain neurological symptoms, but usually does not present with spasticity or elevated carboxylic acids. Key symptoms not reported include developmental delays and specific dietary restrictions.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia, vomiting, and potential obesity. Key symptoms not reported include neurological deficits and developmental delays. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, gastrointestinal inflammation, and vomiting. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease: Symptoms consistent include vomiting and metabolic crisis. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms. 
+4 Urea Cycle Disorder: Symptoms consistent include vomiting and potential metabolic crisis. Key symptoms not reported include hyperammonemia and neurological symptoms. 
+5 Organic Acidemia: Symptoms consistent include vomiting and metabolic instability. Key symptoms not reported include metabolic acidosis and specific organic acid elevations in urine.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Non-ketotic hyperglycinemia: This condition is characterized by elevated glycine levels, aminoaciduria, and neurological symptoms. The patient's increased CSF lactate and metabolic acidosis are consistent with this diagnosis. Key symptoms not reported include seizures or developmental delays.

+2 Mitochondrial disorder: The combination of metabolic acidosis and increased CSF lactate suggests a mitochondrial dysfunction. The patient's symptoms align with potential mitochondrial encephalomyopathies. Key symptoms not reported may include muscle weakness or exercise intolerance.

+3 Maple syrup urine disease: This disorder can present with metabolic acidosis and aminoaciduria. However, the specific elevation of glycine and the skin rash are less typical. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms.

+4 Urea cycle disorder: This could explain the metabolic acidosis and aminoaciduria. However, the specific elevation of glycine and the skin rash are not typical. Key symptoms not reported include hyperammonemia and altered mental status.

+5 Phenylketonuria (PKU): While this condition involves aminoaciduria and can lead to neurological issues, the specific symptoms of increased CSF lactate and the skin rash are not typical. Key symptoms not reported include intellectual disability and musty odor in urine.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia (MMA): Symptoms consistent include decreased methylmalonyl-CoA mutase activity, feeding difficulties, and neonatal death. Key symptoms not reported may include metabolic acidosis and developmental delays.
+2 Propionic acidemia: Symptoms consistent include feeding difficulties and dehydration. Key symptoms not reported may include metabolic acidosis and lethargy.
+3 Organic acidemia: Symptoms consistent include feeding difficulties and dehydration. Key symptoms not reported may include specific organic acid accumulation.
+4 Urea cycle disorders: Symptoms consistent include feeding difficulties and dehydration. Key symptoms not reported may include hyperammonemia and altered mental status.
+5 Other metabolic disorders: Symptoms consistent include feeding difficulties and dehydration. Key symptoms not reported may include specific enzyme deficiencies and metabolic crises.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Propionic acidemia: This condition is characterized by propionyl-CoA carboxylase deficiency, leading to metabolic acidosis, lethargy, hypotonia, and elevated propionic acid in the urine. Key symptoms not reported include specific neurological deficits or developmental delays.

+2 Mitochondrial disorder: These disorders can present with metabolic acidosis, increased lactate, and hypotonia. Key symptoms not reported include myopathy or seizures.

+3 Pyruvate carboxylase deficiency: This condition can lead to increased lactate and hypotonia. Key symptoms not reported include developmental delays or specific neurological symptoms.

+4 Organic acidemia: This group of disorders can present with metabolic acidosis and elevated organic acids in the urine. Key symptoms not reported include specific metabolic crises or episodes of vomiting.

+5 Urea cycle disorder: While less likely, these can present with lethargy and metabolic disturbances. Key symptoms not reported include hyperammonemia or specific neurological symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Hyperphenylalaninemia, abnormality of prenatal development. Key symptoms not reported: Intellectual disability if untreated.
+2 Tyrosinemia: Hypertyrosinemia, abnormality of prenatal development, death in infancy. Key symptoms not reported: Liver dysfunction, renal issues.
+3 Maple Syrup Urine Disease (MSUD): Severe developmental issues, death in infancy. Key symptoms not reported: Specific branched-chain amino acid accumulation.
+4 Urea Cycle Disorders: Death in infancy, neonatal death. Key symptoms not reported: Hyperammonemia, lethargy, vomiting.
+5 Congenital Disorders of Glycosylation (CDG): Abnormality of prenatal development, death in childhood. Key symptoms not reported: Varied symptoms including developmental delays, hypotonia.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Organic Acidemia: This encompasses a range of disorders characterized by the accumulation of organic acids, consistent with dicarboxylic aciduria and 3-methylglutaric aciduria. Key symptoms not reported may include metabolic acidosis and developmental delays.
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This condition can lead to dicarboxylic aciduria and is known for causing metabolic crises in infancy. Key symptoms not reported may include hypoglycemia and lethargy.
+3 3-Hydroxy-3-Methylglutaric Aciduria: Characterized by the accumulation of 3-hydroxy-3-methylglutaric acid, consistent with the patient's symptoms. Key symptoms not reported may include developmental delays and metabolic crises.
+4 Propionic Acidemia: This disorder can lead to dicarboxylic aciduria and is associated with severe symptoms in infancy. Key symptoms not reported may include vomiting, lethargy, and failure to thrive.
+5 Methylmalonic Acidemia: Similar to propionic acidemia, this condition can lead to the accumulation of methylmalonic acid and dicarboxylic acids. Key symptoms not reported may include metabolic acidosis and neurological symptoms.",Hereditary metabolic disorders
['Wilson disease'],"+1 Wilson's disease: This condition is supported by decreased ceruloplasmin, increased urinary copper, and liver dysfunction. Key symptoms not reported include neurological symptoms and Kayser-Fleischer rings.
+2 Porphyria: The abnormal circulating porphyrin concentration suggests this diagnosis. Key symptoms not reported include photosensitivity and abdominal pain.
+3 Non-alcoholic fatty liver disease (NAFLD): The obesity and elevated liver enzymes align with this condition. Key symptoms not reported include fatigue and potential insulin resistance.
+4 Metabolic syndrome: The obesity and liver dysfunction could indicate this syndrome. Key symptoms not reported include hypertension and dyslipidemia.
+5 Amino acid metabolism disorder: The abnormal amino acid concentrations suggest this possibility. Key symptoms not reported include developmental delays or neurological symptoms depending on the specific disorder.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase I Deficiency: This condition is consistent with the abnormal circulating carnitine concentration and can lead to death in infancy. Key symptoms not reported include episodes of hypoglycemia and lethargy.

+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): The abnormal carnitine levels and the history of neonatal death align with this diagnosis. Key symptoms not reported include vomiting and hypoglycemia during fasting.

+3 Congenital Heart Defects: The abnormality of prenatal development and death in infancy could suggest a congenital heart defect. Key symptoms not reported include cyanosis or difficulty breathing.

+4 Mitochondrial Disorders: The combination of symptoms could indicate a mitochondrial disorder, which can lead to severe metabolic crises. Key symptoms not reported include muscle weakness or developmental delays.

+5 Urea Cycle Disorders: While less directly indicated, these disorders can lead to metabolic disturbances and death in infancy. Key symptoms not reported include vomiting, lethargy, and altered mental status.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: This condition is consistent with hypertyrosinemia and could explain the early deaths. Key symptoms not reported include liver failure and renal issues. 
+2 Phenylketonuria (PKU): This aligns with hyperphenylalaninemia. Key symptoms not reported include developmental delays and neurological issues. 
+3 Combined Immunodeficiency: This could explain the recurrent viral infections and early deaths. Key symptoms not reported include failure to thrive and severe infections. 
+4 Maple Syrup Urine Disease (MSUD): This condition could explain some metabolic issues but does not typically present with recurrent infections. Key symptoms not reported include sweet-smelling urine and neurological decline. 
+5 Urea Cycle Disorders: These could lead to metabolic crises and early death but do not typically present with recurrent infections. Key symptoms not reported include vomiting, lethargy, and neurological symptoms during metabolic crises.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1 Non-ketotic hyperglycinemia: This condition is consistent with elevated glycine levels and aminoaciduria. Key symptoms not reported may include neurological symptoms such as seizures or developmental delays. 
+2 Primary carnitine deficiency: This diagnosis fits with abnormal carnitine levels and elevated urinary carboxylic acids. Key symptoms not reported may include muscle weakness or cardiomyopathy. 
+3 Organic acidemia (e.g., propionic acidemia): This condition aligns with elevated urinary carboxylic acids and aminoaciduria. Key symptoms not reported may include metabolic acidosis or failure to thrive. 
+4 Urea cycle disorders: This diagnosis is consistent with aminoaciduria and abnormal amino acid concentrations. Key symptoms not reported may include hyperammonemia or neurological symptoms. 
+5 Maple syrup urine disease (MSUD): This condition can present with aminoaciduria and abnormal amino acid levels. Key symptoms not reported may include a characteristic sweet odor in urine and neurological symptoms.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 3-Methylglutaconic aciduria: This condition is characterized by the presence of 3-methylglutaconic acid in urine, hypotonia, and feeding difficulties. Key symptoms not reported include developmental delays and neurological symptoms. 
+2 Organic acidemia: This diagnosis fits with the hypotonia, hepatomegaly, and metabolic derangement indicated by the aciduria. Key symptoms not reported may include metabolic crises or acidosis. 
+3 Mitochondrial disorder: This could explain the hypotonia and feeding difficulties, but the specific aciduria is less common. Key symptoms not reported include exercise intolerance and seizures. 
+4 Urea cycle disorder: This could present with hypotonia and feeding difficulties, but the hepatomegaly and specific aciduria make it less likely. Key symptoms not reported include hyperammonemia and altered mental status. 
+5 Lysosomal storage disorder: This could explain hypotonia and hepatomegaly, but the specific metabolic profile is not typical. Key symptoms not reported include skeletal abnormalities and progressive neurological decline.",Hereditary metabolic disorders
['Citrullinemia type I'],"+1 Urea Cycle Disorder: This diagnosis is supported by elevated plasma citrulline, hyperammonemia, and orotic aciduria. Key symptoms not reported include seizures or severe neurological deficits, which may occur in acute cases. 
+2 Organic Acidemia: Symptoms consistent with this diagnosis include hypoglycemia, lethargy, and metabolic derangements. Key symptoms not reported may include vomiting or metabolic crises. 
+3 Mitochondrial Disorder: Lethargy, motor delay, and hypothermia align with this condition. Key symptoms not reported could include exercise intolerance or myopathy. 
+4 Genetic Syndrome: The combination of obesity and developmental delays may suggest a genetic syndrome. Key symptoms not reported could include specific facial features or endocrine abnormalities. 
+5 Infectious or Inflammatory Condition: Acute and chronic hepatitis could indicate an infectious process. Key symptoms not reported may include jaundice or abdominal pain.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: This condition is consistent with the patient's history of glutaric aciduria, seizures, hypotonia, and macrocephaly. Key symptoms not reported include developmental delays and specific metabolic crises.
+2 Cerebral Dysgenesis: The combination of macrocephaly and neurological symptoms suggests possible brain malformation. Key symptoms not reported include specific cognitive or developmental milestones.
+3 Hypoxic-Ischemic Encephalopathy: This could explain the neurological symptoms and neonatal death, particularly if there was a perinatal event. Key symptoms not reported include specific signs of acute injury or recovery.
+4 Metabolic Encephalopathy: Other metabolic disorders could present similarly, especially with seizures and hypotonia. Key symptoms not reported include specific metabolic derangements or crises.
+5 Neurodegenerative Disorders: Conditions like Krabbe disease could present with similar symptoms, particularly in infancy. Key symptoms not reported include progressive loss of motor skills or cognitive function.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"+1 Tyrosinemia Type I: Symptoms include elevated tyrosine levels, developmental delays, and potential liver failure. Key symptoms not reported include jaundice and abdominal pain.
+2 Phenylketonuria (PKU): Symptoms include elevated phenylalanine levels and developmental delays. Key symptoms not reported include seizures and behavioral issues.
+3 Alkaptonuria: Symptoms include dark urine and joint problems. Key symptoms not reported include arthritis and heart issues.
+4 Maple Syrup Urine Disease (MSUD): Symptoms include neurological impairment and sweet-smelling urine. Key symptoms not reported include feeding difficulties and lethargy.
+5 Urea Cycle Disorders: Symptoms include hyperammonemia and neurological symptoms. Key symptoms not reported include vomiting and irritability.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and potential developmental issues. Key symptoms not reported include neurological deficits and specific dietary restrictions. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and risk of early mortality. Key symptoms not reported include liver dysfunction and neurological symptoms. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include elevated urinary carboxylic acid. Key symptoms not reported include specific neurological symptoms and characteristic urine odor. 
+4 Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid and potential for early mortality. Key symptoms not reported include metabolic crises and specific organic acid profiles. 
+5 Congenital Disorders of Glycosylation (CDG): Symptoms consistent include prenatal abnormalities and obesity. Key symptoms not reported include developmental delays and specific glycosylation defects.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia, intellectual disability, and seizures. Key symptoms not reported include a specific dietary history or response to phenylalanine restriction.
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, seizures, obesity, and severe short stature. Key symptoms not reported include liver dysfunction or specific urinary metabolites.
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include seizures and intellectual disability. Key symptoms not reported include characteristic maple syrup odor in urine and metabolic crises.
+4 Urea Cycle Disorders: Symptoms consistent include seizures and intellectual disability. Key symptoms not reported include hyperammonemia and specific metabolic derangements.
+5 Mitochondrial Disorders: Symptoms consistent include seizures and developmental delays. Key symptoms not reported include exercise intolerance or specific mitochondrial dysfunction markers.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia (MMA): Symptoms include seizures, vomiting, metabolic acidosis, hyperammonemia, and methylmalonic aciduria. Key symptoms not reported include developmental delays or failure to thrive.

+2 Urea Cycle Disorder: Symptoms include hyperammonemia, metabolic acidosis, and seizures. Key symptoms not reported include lethargy or altered mental status.

+3 Organic Acidemia: Symptoms include metabolic acidosis, vomiting, and seizures. Key symptoms not reported include specific organic acid profiles in urine.

+4 Severe Combined Immunodeficiency (SCID): Symptoms include leukopenia and hypotonia. Key symptoms not reported include recurrent infections or failure to thrive.

+5 Congenital Hypopituitarism: Symptoms include hypotonia and metabolic derangements. Key symptoms not reported include growth failure or specific hormonal deficiencies.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine deficiency: This condition is consistent with the abnormal circulating carnitine concentration and can lead to severe metabolic issues and death in infancy. Key symptoms not reported include muscle weakness and hypoglycemia.

+2 Fatty acid oxidation disorder: This diagnosis aligns with the abnormal carnitine levels and can cause significant health issues in neonates, leading to death. Key symptoms not reported include hypoketotic hypoglycemia and cardiomyopathy.

+3 Congenital metabolic disorder: This broad category includes various conditions that could explain the combination of symptoms, particularly those affecting energy metabolism. Key symptoms not reported may include developmental delays or failure to thrive.

+4 Genetic syndrome (e.g., Zellweger spectrum disorders): These syndromes can lead to both developmental abnormalities and metabolic issues, resulting in neonatal death. Key symptoms not reported may include dysmorphic features or organomegaly.

+5 Congenital heart defect: While this could explain the death in infancy, it is less likely given the abnormal carnitine levels. Key symptoms not reported may include cyanosis or respiratory distress.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia (MMA): Symptoms consistent include methylmalonic aciduria, metabolic acidosis, and hyperammonemia. Key symptoms not reported may include developmental delays or neurological symptoms in surviving infants. 
+2 Propionic Acidemia: Symptoms consistent include metabolic acidosis and hyperammonemia. Key symptoms not reported may include propionic aciduria and specific neurological symptoms. 
+3 Ornithine Transcarbamylase Deficiency (OTC): Symptoms consistent include hyperammonemia and metabolic acidosis. Key symptoms not reported may include elevated orotic acid in urine. 
+4 Isovaleric Acidemia: Symptoms consistent include metabolic acidosis and vomiting. Key symptoms not reported may include characteristic odor of sweaty feet and isovalerylglycine in urine. 
+5 Urea Cycle Disorders: Symptoms consistent include hyperammonemia and metabolic acidosis. Key symptoms not reported may include specific amino acid imbalances and varying presentations based on the specific disorder.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder (OTC deficiency): Hyperammonemia, orotic aciduria, seizures, cerebral edema. Key symptoms not reported: None specifically, but may include lethargy or vomiting. 
+2 Citrullinemia: Hyperammonemia, seizures. Key symptoms not reported: Elevated citrulline levels in plasma. 
+3 Carbamoyl Phosphate Synthetase I Deficiency: Hyperammonemia, seizures. Key symptoms not reported: Specific metabolic derangements in ammonia processing. 
+4 Mitochondrial Disorder: Seizures, cerebral edema. Key symptoms not reported: Muscle weakness, exercise intolerance, or other systemic symptoms. 
+5 Organic Acidemia: Seizures, metabolic derangements. Key symptoms not reported: Specific organic acid profiles in urine.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1: Urea Cycle Disorder: Symptoms consistent include elevated urinary carboxylic acid, seizures, and hypotonia. Key symptoms not reported include hyperammonemia and specific metabolic derangements.
+2: Mitochondrial Disorder: Symptoms consistent include seizures, hypotonia, and growth delay. Key symptoms not reported include specific mitochondrial myopathy features and lactic acidosis.
+3: Menkes Disease: Symptoms consistent include seizures, hypotonia, alopecia, and growth delay. Key symptoms not reported include characteristic hair abnormalities and copper deficiency.
+4: Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid, seizures, and hypotonia. Key symptoms not reported include metabolic acidosis and specific organic acid profiles.
+5: Spinal Muscular Atrophy (SMA): Symptoms consistent include generalized hypotonia and fasciculations. Key symptoms not reported include progressive muscle weakness and respiratory difficulties.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and potential obesity. Key symptoms not reported include neurological deficits or developmental delays.
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and potential obesity. Key symptoms not reported include liver dysfunction or acute metabolic crises.
+3 Metabolic syndrome: Symptoms consistent include obesity and hypercholesterolemia. Key symptoms not reported include insulin resistance or hypertension.
+4 Urea cycle disorder: Symptoms consistent include hyperphenylalaninemia and hypertyrosinemia. Key symptoms not reported include acute metabolic crises or neurological symptoms.
+5 Genetic metabolic syndrome: Symptoms consistent include obesity, hypercholesterolemia, and metabolic abnormalities. Key symptoms not reported include specific genetic markers or family history of similar conditions.",Hereditary metabolic disorders
['Phenylketonuria'],"+1: Turner Syndrome: This condition is characterized by short stature and can be associated with congenital anomalies such as hypospadias. The patient’s severe short stature aligns with this diagnosis, although Turner syndrome typically does not present with hypertyrosinemia or hyperphenylalaninemia.

+2: Phenylketonuria (PKU): This metabolic disorder is characterized by hyperphenylalaninemia due to a deficiency in phenylalanine hydroxylase. The patient’s symptoms of hyperphenylalaninemia and severe short stature could fit, but PKU does not typically present with hypospadias or hernia.

+3: Tyrosinemia: This condition is associated with hypertyrosinemia and can lead to severe health issues if untreated. The presence of hypertyrosinemia and severe short stature supports this diagnosis, but it does not typically include hypospadias.

+4: Prader-Willi Syndrome: This genetic disorder can present with severe short stature, hypogonadism, and other developmental issues. While it does not directly explain hypospadias or the metabolic conditions, the combination of symptoms could suggest a broader genetic syndrome.

+5: Congenital Adrenal Hyperplasia (CAH): This condition can lead to ambiguous genitalia (which may include hypospadias) and can be associated with growth issues. The presence of hernia and severe short stature could fit, but CAH typically does not present with the specific metabolic disorders noted.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome: This condition is characterized by microcephaly, intellectual disability, developmental delays, syndactyly, and elevated 7-dehydrocholesterol levels, all of which are present in the patient.
+2 Down Syndrome: While the patient exhibits some features consistent with Down syndrome (e.g., strabismus, developmental delays), the specific biochemical markers and other physical anomalies do not align as closely.
+3 Cornelia de Lange Syndrome: This syndrome includes growth delays and intellectual disability, but the specific combination of symptoms and biochemical findings does not fit well.
+4 Patau Syndrome (Trisomy 13): This condition can present with microcephaly and various anomalies, but the specific developmental and biochemical profile is not typical for this syndrome.
+5 Other metabolic disorders: Conditions like Zellweger syndrome could be considered, but the specific symptoms and elevated cholesterol levels point more towards Smith-Lemli-Opitz Syndrome.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms include ataxia, opisthotonus, progressive neurologic deterioration, elevated glutaric acid concentration, and abnormal acylcarnitine concentration. Key symptoms not reported include specific metabolic crises or acute episodes.

+2 Organic Acidemia: Symptoms include ataxia and neurologic deterioration. Key symptoms not reported include specific organic acid profiles that could differentiate between types.

+3 Urea Cycle Disorder: Symptoms may include neurological symptoms and metabolic crises. Key symptoms not reported include hyperammonemia or specific amino acid imbalances.

+4 Mitochondrial Disorder: Symptoms may include neurological deterioration and metabolic disturbances. Key symptoms not reported include exercise intolerance or specific mitochondrial dysfunction markers.

+5 Carnitine Deficiency: Symptoms include neurological symptoms and metabolic crises. Key symptoms not reported include specific muscle weakness or cardiomyopathy.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia, motor delay, and hypotonia. Key symptoms not reported include intellectual disability if untreated. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, motor delay, and hypotonia. Key symptoms not reported include liver dysfunction and potential renal issues. 
+3 Congenital disorders of glycosylation: Symptoms consistent include motor delay, hypotonia, and potential developmental delays. Key symptoms not reported include specific organ system involvement. 
+4 Syndromic conditions (e.g., Down syndrome, Turner syndrome): Symptoms consistent include motor delay and hypotonia. Key symptoms not reported include characteristic physical features and other systemic anomalies. 
+5 Metabolic storage disorders: Symptoms consistent include motor delay, hypotonia, and potential developmental delays. Key symptoms not reported include organomegaly or specific neurological symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Metabolic Disorder (e.g., Tyrosinemia): This condition is consistent with hypertyrosinemia and can lead to neurological symptoms, seizures, and hypotonia. Key symptoms not reported include liver dysfunction and failure to thrive. 
+2 Phenylketonuria (PKU): The presence of hyperphenylalaninemia aligns with this diagnosis, which can cause neurological impairment and seizures. Key symptoms not reported include developmental delays and behavioral issues. 
+3 Congenital Malformation Syndrome (e.g., Pierre Robin Sequence): Retrognathia and apnea could suggest this syndrome, which can also lead to hypotonia and feeding difficulties. Key symptoms not reported include cleft palate and respiratory distress. 
+4 Neuromuscular Disorder (e.g., Spinal Muscular Atrophy): Generalized hypotonia and seizures could indicate a neuromuscular condition. Key symptoms not reported include muscle weakness and atrophy. 
+5 Neurodegenerative Disorder (e.g., Batten Disease): The combination of seizures, hypotonia, and early mortality could suggest a neurodegenerative process. Key symptoms not reported include vision loss and cognitive decline.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia, intellectual disability, and seizures. Key symptoms not reported include a musty odor in urine. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, seizures, and intellectual disability. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Urea Cycle Disorders: Symptoms consistent include abnormal amino acid concentrations and seizures. Key symptoms not reported include hyperammonemia and lethargy. 
+4 Autism Spectrum Disorder (ASD) with Comorbid Conditions: Symptoms consistent include autistic behavior, self-mutilation, and intellectual disability. Key symptoms not reported include social communication deficits. 
+5 Metabolic Syndrome or Genetic Syndrome: Symptoms consistent include obesity, motor delay, and metabolic abnormalities. Key symptoms not reported include endocrine dysfunction and specific genetic markers.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: This condition is characterized by hypergalactosemia, vomiting, and increased bilirubin levels. Key symptoms not reported include cataracts and failure to thrive.
+2 Biliary Atresia: Increased bilirubin and vomiting are consistent with this diagnosis, but it does not explain hypergalactosemia. Key symptoms not reported include pale stools and dark urine.
+3 Urea Cycle Disorder: While this could explain some symptoms, it does not account for hypergalactosemia. Key symptoms not reported include lethargy and seizures.
+4 Tyrosinemia: This could lead to liver dysfunction and increased bilirubin but does not explain hypergalactosemia. Key symptoms not reported include cabbage-like odor and renal issues.
+5 Other Metabolic Disorders: Various other metabolic disorders could be considered, but they would need specific testing to confirm. Key symptoms not reported would vary depending on the specific disorder.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and abnormal circulating tyrosine concentration. Key symptoms not reported include neurological impairment or developmental delays.
+2 Tyrosinemia: Symptoms consistent include abnormal circulating tyrosine concentration. Key symptoms not reported include liver dysfunction or failure.
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include metabolic disturbances leading to severe outcomes in infancy. Key symptoms not reported include specific neurological symptoms such as lethargy or seizures.
+4 Congenital Heart Defects: Symptoms consistent include abnormality of prenatal development or birth and death in infancy. Key symptoms not reported include specific cardiac symptoms or failure.
+5 Other metabolic disorders: Symptoms consistent include hyperphenylalaninemia and abnormal circulating tyrosine concentration. Key symptoms not reported vary widely depending on the specific disorder.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Primary Carnitine Deficiency: This condition is characterized by low levels of carnitine, leading to metabolic issues. The patient's abnormal circulating carnitine concentration and obesity are consistent with this diagnosis. Key symptoms not reported include muscle weakness and hypoglycemia.

+2 Carnitine Palmitoyltransferase I or II Deficiency: These deficiencies lead to an inability to utilize fatty acids for energy, resulting in obesity and abnormal carnitine levels. The patient's symptoms align well with this diagnosis. Key symptoms not reported include episodes of hypoglycemia and muscle pain.

+3 Mitochondrial Myopathy: This condition can cause metabolic dysfunction and obesity, but the specific abnormal carnitine levels make it less likely. Key symptoms not reported include exercise intolerance and muscle weakness.

+4 Urea Cycle Disorder: While this could explain early death in childhood, it does not typically present with obesity or abnormal carnitine levels. Key symptoms not reported include hyperammonemia and neurological symptoms.

+5 Other Fatty Acid Oxidation Disorders: These disorders can lead to metabolic crises and obesity, but the specific combination of symptoms points more towards carnitine-related issues. Key symptoms not reported include hypoglycemia and lethargy during fasting.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is consistent with hyperphenylalaninemia and intellectual disability. Key symptoms not reported include seizures and behavioral issues. 
+2 Tyrosinemia: This aligns with hypertyrosinemia, intellectual disability, and the potential for early death. Key symptoms not reported include liver dysfunction and failure to thrive. 
+3 Maple Syrup Urine Disease (MSUD): This condition is consistent with intellectual disability and could lead to death in infancy. Key symptoms not reported include sweet-smelling urine and lethargy. 
+4 Congenital Disorders of Glycosylation (CDG): This could explain the intellectual disability and early mortality. Key symptoms not reported include failure to thrive and various systemic issues. 
+5 Smith-Lemli-Opitz Syndrome (SLOS): This syndrome could account for the intellectual disability and congenital abnormalities. Key symptoms not reported include physical malformations and behavioral issues.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Genetic Syndrome (e.g., Smith-Lemli-Opitz Syndrome): Symptoms consistent include cryptorchidism, hypospadias, microcephaly, elevated 7-dehydrocholesterol, and intellectual disability. Key symptoms not reported may include behavioral issues and specific facial dysmorphisms.

+2 Congenital Disorder of Glycosylation: Symptoms consistent include developmental delays, hypotonia, and feeding difficulties. Key symptoms not reported may include liver dysfunction or coagulopathy.

+3 Turner Syndrome: Symptoms consistent include low-set ears, strabismus, and developmental delays. Key symptoms not reported may include short stature and cardiac anomalies.

+4 22q11.2 Deletion Syndrome: Symptoms consistent include congenital heart defects, developmental delays, and immune deficiencies. Key symptoms not reported may include palatal abnormalities and psychiatric disorders.

+5 Kallmann Syndrome: Symptoms consistent include cryptorchidism, hypospadias, and intellectual disability. Key symptoms not reported may include anosmia (loss of smell) and delayed puberty.",Hereditary metabolic disorders
['Canavan disease'],"+1 Prader-Willi Syndrome: This condition is consistent with obesity, hypotonia, and strabismus. Key symptoms not reported include developmental delays and behavioral issues. 
+2 Mitochondrial Disease: This could explain the neurological symptoms, hypotonia, and cerebral atrophy. Key symptoms not reported include exercise intolerance and seizures. 
+3 Urea Cycle Disorder: The abnormal amino acid concentration aligns with this diagnosis, along with potential neurological symptoms. Key symptoms not reported include vomiting and lethargy during metabolic crises. 
+4 Spinal Muscular Atrophy: This could explain the hypotonia and hyporeflexia. Key symptoms not reported include muscle weakness and atrophy. 
+5 Congenital Myopathy: This could account for hypotonia and strabismus. Key symptoms not reported include muscle weakness and delayed motor milestones.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and could explain the obesity and potential cardiovascular issues. Key symptoms not reported include liver dysfunction and neurological symptoms.
+2 Congenital Heart Disease: The coarctation of the aorta aligns with this diagnosis, which could also be part of a syndrome. Key symptoms not reported include other congenital anomalies or specific heart-related symptoms.
+3 Phenylketonuria (PKU): This diagnosis fits with hyperphenylalaninemia but does not explain obesity or coarctation of the aorta. Key symptoms not reported include developmental delays and neurological issues.
+4 Prader-Willi Syndrome: This syndrome explains obesity and developmental issues but does not account for the metabolic disorders or coarctation of the aorta. Key symptoms not reported include hypogonadism and behavioral issues.
+5 Metabolic Syndrome: This could explain obesity and cardiovascular issues but does not account for the early deaths or specific metabolic disorders. Key symptoms not reported include insulin resistance and dyslipidemia.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: This condition is characterized by hyperhomocystinemia and can lead to developmental delays and early mortality, consistent with the patient's symptoms of neonatal death and death in childhood.
+2 Methionine adenosyltransferase deficiency: This disorder leads to hypermethioninemia and can cause neurological issues, aligning with the patient's aminoaciduria and severe outcomes.
+3 Cystathionine beta-synthase deficiency: A form of homocystinuria that results in similar symptoms, including developmental delays and early mortality, consistent with the patient's presentation.
+4 Maple syrup urine disease (MSUD): While primarily associated with branched-chain amino acids, the presence of aminoaciduria suggests a broader metabolic issue, though the specific symptoms may not fully align.
+5 Urea cycle disorders: These can lead to severe neurological impairment and death, but the specific symptoms of hyperhomocystinemia and hypermethioninemia are not typical, making this a less likely diagnosis.",Hereditary metabolic disorders
[],"+1 Pyrimidine Metabolism Disorder: This condition explains the abnormal circulating pyrimidine concentration and uraciluria, along with ataxia and hypotonia. Key symptoms not reported include developmental delays and seizures. 
+2 Mitochondrial Disorder: Ataxia and hypotonia are consistent with this diagnosis, and some mitochondrial disorders can lead to early mortality. Key symptoms not reported may include myopathy or cardiomyopathy. 
+3 Urea Cycle Disorder: While ataxia and hypotonia can be present, the specific metabolic markers do not align well. Key symptoms not reported include hyperammonemia and lethargy. 
+4 Cerebral Folate Deficiency: This could lead to ataxia and hypotonia, but is usually associated with seizures and developmental delays. Key symptoms not reported include cognitive decline. 
+5 Lysosomal Storage Disorder: Ataxia and hypotonia are consistent, but abnormal pyrimidine levels are not typical. Key symptoms not reported include organomegaly or cherry-red spots on the retina.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: Symptoms include hypertyrosinemia and potential liver failure. Key symptoms not reported include jaundice and abdominal pain. 
+2 Phenylketonuria (PKU): Symptoms include hyperphenylalaninemia and neurological issues. Key symptoms not reported include developmental delays and seizures. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms include neurological issues and elevated branched-chain amino acids. Key symptoms not reported include sweet-smelling urine and feeding difficulties. 
+4 Alkaptonuria: Symptoms include dark urine and arthritis. Key symptoms not reported include ochronosis and heart disease. 
+5 Combined Hyperphenylalaninemia and Tyrosinemia: Symptoms include both elevated tyrosine and phenylalanine levels. Key symptoms not reported include specific metabolic crisis symptoms.",Hereditary metabolic disorders
[],"+1 Pyrimidine Metabolism Disorder: This includes conditions like orotic aciduria or dihydropyrimidine dehydrogenase deficiency. Symptoms consistent with this diagnosis include abnormal circulating pyrimidine concentration and uraciluria. Key symptoms not reported may include developmental delays or neurological symptoms in surviving infants. 
+2 Urea Cycle Disorder: This could explain metabolic issues and respiratory insufficiency. Symptoms consistent with this diagnosis include respiratory insufficiency. Key symptoms not reported may include hyperammonemia and neurological symptoms. 
+3 Mitochondrial Disorder: This could lead to respiratory insufficiency and early death. Symptoms consistent with this diagnosis include respiratory insufficiency. Key symptoms not reported may include muscle weakness or exercise intolerance. 
+4 Genetic Syndrome: Certain genetic syndromes could present with these symptoms. Symptoms consistent with this diagnosis include death in infancy and respiratory insufficiency. Key symptoms not reported may include specific dysmorphic features or other systemic involvement. 
+5 Cerebrospinal Fluid Disorder: This could lead to respiratory issues but does not directly correlate with the metabolic symptoms observed. Symptoms consistent with this diagnosis include respiratory insufficiency. Key symptoms not reported may include seizures or other neurological deficits.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"+1 Hepatic dysfunction: Symptoms include ascites, hypoalbuminemia, elevated alkaline phosphatase, and elevated alpha-fetoprotein. Key symptoms not reported include jaundice and pruritus. 
+2 Tyrosinemia: Symptoms include hypertyrosinemia, aminoaciduria, and potential liver dysfunction. Key symptoms not reported include neurological symptoms and failure to thrive. 
+3 Hepatoblastoma: Symptoms include elevated alpha-fetoprotein and ascites. Key symptoms not reported include abdominal mass and weight loss. 
+4 Wilson's disease: Symptoms include anemia, thrombocytosis, and liver dysfunction. Key symptoms not reported include neurological symptoms and Kayser-Fleischer rings. 
+5 Congenital liver disease: Symptoms include ascites and hypoalbuminemia. Key symptoms not reported include cholestasis and failure to thrive.",Hereditary metabolic disorders
['Canavan disease'],"+1 Urea Cycle Disorder: Consistent with seizures, motor delay, and abnormal amino acid concentrations. Key symptoms not reported include hyperammonemia.
+2 Maple Syrup Urine Disease: Consistent with seizures and motor delay. Key symptoms not reported include characteristic sweet-smelling urine and specific amino acid elevations (leucine, isoleucine, valine).
+3 Non-ketotic Hyperglycinemia: Consistent with seizures and motor delay. Key symptoms not reported include hypotonia and elevated glycine levels.
+4 Pyridoxine-dependent Epilepsy: Consistent with seizures and motor delay. Key symptoms not reported include responsiveness to vitamin B6 treatment.
+5 Mitochondrial Disorder: Consistent with seizures, motor delay, and early mortality. Key symptoms not reported include exercise intolerance and lactic acidosis.",Hereditary metabolic disorders
['Isovaleric acidemia'],"+1 Urea Cycle Disorder: This condition could explain the abnormal glycine and carnitine levels, recurrent infections, and gastrointestinal symptoms. Key symptoms not reported include hyperammonemia and neurological symptoms. 
+2 Organic Acidemia: Conditions like propionic acidemia could lead to similar symptoms, including vomiting and diarrhea. Key symptoms not reported include metabolic acidosis and lethargy during metabolic crises. 
+3 Maple Syrup Urine Disease (MSUD): Characterized by body odor and metabolic derangements, this condition aligns with some symptoms. Key symptoms not reported include neurological decline and specific metabolic crises. 
+4 Glycine Encephalopathy: Elevated glycine levels could explain some symptoms, but gastrointestinal issues are less common. Key symptoms not reported include seizures and developmental delays. 
+5 Carnitine Transport Defect: This could explain the abnormal carnitine levels and metabolic crises. Key symptoms not reported include muscle weakness and cardiomyopathy.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: This condition is consistent with hypertyrosinemia, intellectual disability, and obesity. Key symptoms not reported include liver dysfunction and potential neurological crises.
+2 Phenylketonuria (PKU): Consistent with hyperphenylalaninemia and intellectual disability. Key symptoms not reported include seizures and behavioral issues.
+3 Bardet-Biedl Syndrome: Consistent with obesity and intellectual disability. Key symptoms not reported include polydactyly and retinal degeneration.
+4 Urea Cycle Disorders: Consistent with elevated urinary carboxylic acid. Key symptoms not reported include hyperammonemia and acute neurological symptoms.
+5 Maple Syrup Urine Disease (MSUD): Consistent with neurological impairment. Key symptoms not reported include characteristic sweet-smelling urine and feeding difficulties in infancy.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Metabolic Disorder (e.g., Urea Cycle Disorder): Symptoms include hyperalaninemia and severe developmental issues. Key symptoms not reported may include vomiting, lethargy, or neurological symptoms. 
+2 Fatty Acid Oxidation Disorder: Abnormal circulating carnitine concentration aligns with this diagnosis. Key symptoms not reported may include hypoglycemia or cardiomyopathy. 
+3 Congenital Disorders of Glycosylation: Can present with growth retardation and hearing impairment. Key symptoms not reported may include hypotonia or seizures. 
+4 Mitochondrial Disorder: Can lead to developmental delays and metabolic crises. Key symptoms not reported may include muscle weakness or exercise intolerance. 
+5 Genetic Syndromes (e.g., Alpers Syndrome): Associated with developmental delays, hearing loss, and metabolic issues. Key symptoms not reported may include seizures or liver dysfunction.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine transcarbamylase deficiency: This condition is consistent with lethargy, drowsiness, sleep abnormalities, orotic aciduria, and abnormal circulating ornithine concentration. Key symptoms not reported include hyperammonemia and potential neurological deficits. 
+2 Carbamoyl phosphate synthetase I deficiency: This diagnosis aligns with the same symptoms, particularly orotic aciduria and abnormal ornithine levels. Key symptoms not reported may include severe metabolic crises and hyperammonemia. 
+3 Citrullinemia: This condition could explain the abnormal ornithine concentration and some lethargy. However, it typically presents with more pronounced neurological symptoms. Key symptoms not reported include elevated citrulline levels. 
+4 Urea cycle disorders (general): This category encompasses various conditions that could explain the symptoms, but specific diagnoses are more fitting. Key symptoms not reported vary widely depending on the specific disorder. 
+5 Mitochondrial disorders: While some symptoms overlap, the specific metabolic markers suggest a urea cycle disorder is more likely. Key symptoms not reported may include myopathy or exercise intolerance.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms include ataxia, dystonia, and glutaric aciduria. Key symptoms not reported include episodes of metabolic crisis or acute neurological deterioration. 
+2 Carnitine Palmitoyltransferase Deficiency: Symptoms include decreased plasma free carnitine and neurological issues like ataxia. Key symptoms not reported include hypoglycemia or muscle weakness during fasting. 
+3 Leukodystrophies: Symptoms include abnormal myelination and neurological deficits like ataxia and dystonia. Key symptoms not reported include progressive cognitive decline or seizures. 
+4 Mitochondrial Disorders: Symptoms include ataxia, dystonia, and metabolic issues. Key symptoms not reported include exercise intolerance or lactic acidosis. 
+5 Congenital Disorders of Glycosylation: Symptoms include abnormal cerebral morphology and neurological symptoms. Key symptoms not reported include failure to thrive or developmental delays.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia and can lead to severe neurological damage and death in untreated infants. Key symptoms not reported include developmental delays and seizures. 
+2 Tyrosinemia: This disorder can also present with hyperphenylalaninemia but typically includes liver dysfunction and renal issues, which are not mentioned. 
+3 Maple Syrup Urine Disease (MSUD): While it can cause elevated amino acids, it is characterized by a distinct odor in urine and neurological symptoms, which are absent in this case. 
+4 Urea Cycle Disorders: These can lead to hyperammonemia and may present with similar symptoms, but they typically involve other metabolic derangements. 
+5 Other rare metabolic disorders: There are several less common conditions that could lead to hyperphenylalaninemia, but they are less likely given the classic presentation of PKU.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"+1 Carnitine deficiency: Symptoms consistent include decreased plasma free carnitine, hypoglycemia, cardiomyopathy, and irritability. Key symptoms not reported include muscle weakness or myopathy.
+2 Mitochondrial disorder: Symptoms consistent include encephalopathy, cardiomyopathy, and generalized hypotonia. Key symptoms not reported include exercise intolerance or lactic acidosis.
+3 Glycogen storage disease: Symptoms consistent include hypoglycemia, hepatomegaly, and vomiting. Key symptoms not reported include muscle cramps or elevated creatine kinase.
+4 Urea cycle disorder: Symptoms consistent include abnormal amino acid concentrations and encephalopathy. Key symptoms not reported include hyperammonemia or respiratory alkalosis.
+5 Porphyria: Symptoms consistent include abnormal circulating porphyrin concentration and irritability. Key symptoms not reported include photosensitivity or abdominal pain.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Cerebellar Dysgenesis: Symptoms include cerebellar agenesis, ataxia, and hypotonia. Key symptoms not reported include specific cognitive impairments or seizures.
+2 Joubert Syndrome: Symptoms include ataxia, nystagmus, and developmental delays. Key symptoms not reported include breathing abnormalities or eye movement disorders.
+3 Urea Cycle Disorders: Symptoms include encephalopathy and growth delay. Key symptoms not reported include acute metabolic crises or specific neurological deficits.
+4 Dandy-Walker Malformation: Symptoms include cerebellar atrophy and hypotonia. Key symptoms not reported include cystic enlargement of the fourth ventricle or developmental delays.
+5 Neurodegenerative Disorders: Symptoms include ataxia and hypotonia. Key symptoms not reported include progressive loss of skills or specific neurodegenerative signs.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: Symptoms consistent include hyperhomocystinemia, ectopia lentis, intellectual disability, and delayed speech. Key symptoms not reported may include skeletal abnormalities or thromboembolic events. 
+2 Marfan syndrome: Symptoms consistent include myopia and ectopia lentis. Key symptoms not reported may include tall stature, arachnodactyly, or cardiovascular issues. 
+3 Cystathionine beta-synthase deficiency: Symptoms consistent include hyperhomocystinemia and intellectual disability. Key symptoms not reported may include seizures or developmental delays. 
+4 Phenylketonuria (PKU): Symptoms consistent include aminoaciduria and intellectual disability. Key symptoms not reported may include a musty odor in urine or skin rashes. 
+5 Maple syrup urine disease: Symptoms consistent include aminoaciduria and dyskinesia. Key symptoms not reported may include a characteristic sweet odor in urine or severe neurological symptoms.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine Transcarbamylase Deficiency: Symptoms consistent include hyperammonemia, orotic aciduria, seizures, ataxia, and lethargy. Key symptoms not reported may include specific neurological deficits or developmental delays. 
+2 Urea Cycle Disorder (General): Symptoms consistent include hyperammonemia, metabolic acidosis, and neurological symptoms. Key symptoms not reported may include specific enzyme deficiencies or variations in ammonia levels. 
+3 Maple Syrup Urine Disease: Symptoms consistent include lethargy, seizures, and metabolic acidosis. Key symptoms not reported may include characteristic sweet-smelling urine and specific amino acid imbalances. 
+4 Mitochondrial Encephalomyopathy: Symptoms consistent include seizures, ataxia, and lethargy. Key symptoms not reported may include muscle weakness or exercise intolerance. 
+5 Pyruvate Dehydrogenase Deficiency: Symptoms consistent include lethargy, drowsiness, and neurological symptoms. Key symptoms not reported may include lactic acidosis and specific metabolic derangements.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome: This condition is characterized by microcephaly, intellectual disability, syndactyly, and elevated 7-dehydrocholesterol levels. Key symptoms not reported include cardiac defects and genital abnormalities. 
+2 Cholesterol Biosynthesis Disorders: This includes a range of metabolic disorders affecting cholesterol synthesis, which could explain the biochemical abnormalities. Key symptoms not reported may include specific physical malformations or other metabolic signs.
+3 Other Genetic Syndromes: Conditions like Down syndrome could present with some overlapping features, but the specific biochemical markers and the combination of symptoms lean more towards SLOS. Key symptoms not reported include distinct facial features or congenital heart defects.
+4 Neuromuscular Disorders: Conditions such as spinal muscular atrophy could explain hypotonia and ataxia but would not typically present with the other features like syndactyly. Key symptoms not reported include muscle weakness or respiratory issues.
+5 Metabolic Disorders: Other metabolic disorders could be considered, but the specific combination of symptoms and biochemical findings strongly suggests a primary diagnosis of SLOS. Key symptoms not reported may include metabolic crises or specific organ dysfunctions.",Hereditary metabolic disorders
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"+1 Mitochondrial myopathy: This condition is consistent with generalized hypotonia and increased lactate concentration. Key symptoms not reported include exercise intolerance and muscle weakness.
+2 Glycogen storage disease: This could explain hypotonia, hepatomegaly, and metabolic derangements. Key symptoms not reported include hypoglycemia and growth retardation.
+3 Fatty acid oxidation disorder: This could account for hypotonia and hypertriglyceridemia. Key symptoms not reported include hypoketotic hypoglycemia and cardiomyopathy.
+4 Organic acidemia: This could explain the increased lactate and abnormal amino acid concentrations. Key symptoms not reported include metabolic acidosis and developmental delays.
+5 Urea cycle disorder: This could explain the abnormal amino acid concentrations. Key symptoms not reported include hyperammonemia and neurological symptoms.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms include microcephaly, generalized hypotonia, athetosis, and cerebral cortical atrophy. Key symptoms not reported include episodes of metabolic crisis or acute neurological deterioration. 
+2 Carnitine Palmitoyltransferase Deficiency: Symptoms include hypotonia and neurological impairment. Key symptoms not reported include hypoketotic hypoglycemia or muscle weakness during fasting. 
+3 Mitochondrial Disorder: Symptoms include hypotonia and neurological decline. Key symptoms not reported include exercise intolerance or myopathy. 
+4 Lysosomal Storage Disorder (e.g., Krabbe Disease): Symptoms include hypotonia and progressive neurological decline. Key symptoms not reported include seizures or vision problems. 
+5 Peroxisomal Disorder (e.g., X-Linked Adrenoleukodystrophy): Symptoms include neurological symptoms and metabolic abnormalities. Key symptoms not reported include adrenal insufficiency or behavioral changes.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Non-ketotic hyperglycinemia (NKH): Hyperglycinemia, hyperglycinuria, vomiting, death in infancy and childhood. Key symptoms not reported include neurological symptoms such as seizures or developmental delays. 
+2 Urea cycle disorder: Hyperammonemia, vomiting, death in infancy and childhood, abnormal circulating glutamine concentration. Key symptoms not reported include lethargy, irritability, or altered mental status. 
+3 Organic acidemia: Elevated urinary carboxylic acid, vomiting, death in infancy and childhood. Key symptoms not reported include metabolic acidosis or failure to thrive. 
+4 Fatty acid oxidation disorder: Abnormal circulating carnitine concentration, vomiting, death in infancy and childhood. Key symptoms not reported include hypoglycemia or cardiomyopathy. 
+5 Glycine encephalopathy: Hyperglycinemia, hyperglycinuria, vomiting, death in infancy and childhood. Key symptoms not reported include hypotonia or developmental delays.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid and abnormal circulating monocarboxylic acid concentration. Key symptoms not reported may include metabolic crises or acidosis episodes. 
+2 Mitochondrial Disorder: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported may include exercise intolerance or myopathy. 
+3 Congenital Malformation Syndromes: Symptoms consistent include abnormal facial shape and intellectual disability. Key symptoms not reported may include specific limb or organ malformations. 
+4 Craniosynostosis Syndromes: Symptoms consistent include abnormal calvaria morphology and intellectual disability. Key symptoms not reported may include specific craniofacial dysmorphisms. 
+5 Peroxisomal Disorders: Symptoms consistent include abnormal facial shape and motor delay. Key symptoms not reported may include hepatomegaly or vision problems.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: Symptoms consistent include hypergalactosemia, hepatic failure, and developmental delays. Key symptoms not reported may include cataracts and renal issues. 
+2 Urea Cycle Disorder: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported may include episodes of hyperammonemia and vomiting. 
+3 Tyrosinemia: Symptoms consistent include hepatic failure and developmental delays. Key symptoms not reported may include renal tubular dysfunction and a specific odor in urine. 
+4 Maple Syrup Urine Disease: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported may include characteristic sweet-smelling urine and episodes of metabolic crisis. 
+5 Fructose Intolerance: Symptoms consistent include diarrhea and hepatic failure. Key symptoms not reported may include hypoglycemia and aversion to fructose-containing foods.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1 Ornithine transcarbamylase deficiency (OTC deficiency): Hyperammonemia, elevated plasma citrulline, aminoaciduria. Key symptoms not reported: Neurological symptoms such as lethargy or seizures. 
+2 Citrullinemia: Elevated plasma citrulline, hyperammonemia, aminoaciduria. Key symptoms not reported: Potential neurological symptoms and failure to thrive. 
+3 Argininosuccinic aciduria: Elevated plasma citrulline, hyperammonemia, aminoaciduria. Key symptoms not reported: Developmental delays and specific neurological symptoms. 
+4 Hyperprolinemia: Abnormal circulating proline concentration, aminoaciduria. Key symptoms not reported: May not present with hyperammonemia, which is a critical symptom here. 
+5 Other organic acidemias: Hyperammonemia, aminoaciduria. Key symptoms not reported: Specific metabolic derangements that could lead to similar presentations.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: Symptoms consistent include hypertyrosinemia and recurrent infections. Key symptoms not reported include liver dysfunction and neurological symptoms. 
+2 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and developmental issues. Key symptoms not reported include intellectual disability and behavioral problems. 
+3 Urea Cycle Disorder: Symptoms consistent include recurrent infections and metabolic crisis. Key symptoms not reported include hyperammonemia and neurological symptoms. 
+4 Porphyria: Symptoms consistent include abnormal circulating porphyrin concentration and possible neurological symptoms. Key symptoms not reported include photosensitivity and abdominal pain. 
+5 Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid and metabolic disturbances. Key symptoms not reported include failure to thrive and developmental delays.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include elevated leucine concentration, lethargy, hypotonia, and body odor. Key symptoms not reported may include feeding difficulties and neurological decline during metabolic crises. 
+2 Urea Cycle Disorder: Symptoms consistent include lethargy, drowsiness, and hypotonia. Key symptoms not reported may include vomiting, irritability, and seizures. 
+3 Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid, lethargy, and hypotonia. Key symptoms not reported may include metabolic acidosis and failure to thrive. 
+4 Mitochondrial Disorder: Symptoms consistent include lethargy, hypotonia, and drowsiness. Key symptoms not reported may include exercise intolerance and recurrent infections. 
+5 Phenylketonuria (PKU): Symptoms consistent include lethargy and hypotonia. Key symptoms not reported may include developmental delays and a musty body odor.",Hereditary metabolic disorders
['Phenylketonuria'],"+1: Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and generalized hypotonia. Key symptoms not reported include developmental delays and seizures. 
+2: Tyrosinemia: Symptoms consistent include hypertyrosinemia and generalized hypotonia. Key symptoms not reported include liver dysfunction and renal issues. 
+3: Iron deficiency anemia: Symptoms consistent include anemia and decreased circulating iron and ferritin concentrations. Key symptoms not reported include fatigue and pallor. 
+4: Metabolic syndrome (inherited metabolic disorder): Symptoms consistent include generalized hypotonia and multiple metabolic abnormalities. Key symptoms not reported include specific organ dysfunctions. 
+5: Vitamin D deficiency or related disorders: Symptoms consistent include abnormality of vitamin D metabolism. Key symptoms not reported include bone pain or deformities.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"<thinking> 
The patient presents with a complex array of symptoms that suggest a genetic or metabolic disorder. Key symptoms that stand out include hypertelorism, anteverted nares, syndactyly, intellectual disability, and severe hearing impairment. The presence of self-mutilation and hyperactivity may indicate a neurological or behavioral component, while the metabolic abnormalities such as hypocholesterolemia and elevated 8-dehydrocholesterol and 7-dehydrocholesterol concentrations suggest a possible disorder of cholesterol metabolism.

1. **Key Symptoms Analysis**: 
   - **Hypertelorism and Anteverted Nares**: These facial dysmorphisms can be associated with various syndromic conditions.
   - **Syndactyly**: This suggests a possible genetic syndrome, as it is often seen in conditions like Smith-Lemli-Opitz syndrome (SLOS).
   - **Intellectual Disability and Delayed Speech**: These developmental delays are common in many genetic syndromes.
   - **Seizures and Motor Delay**: These neurological symptoms could indicate a more severe underlying condition.
   - **Death in Infancy and Childhood**: This raises concern for a severe genetic disorder with a poor prognosis.

2. **Possible Diagnoses**:
   - **Smith-Lemli-Opitz Syndrome (SLOS)**: This condition is characterized by the combination of dysmorphic features (hypertelorism, anteverted nares), syndactyly, intellectual disability, and metabolic abnormalities (elevated 7-dehydrocholesterol). The presence of hypocholesterolemia is also a hallmark of this syndrome.
   - **Cornelia de Lange Syndrome**: This syndrome can present with similar facial features and developmental delays, but the specific metabolic abnormalities and self-mutilation are less common.
   - **Patau Syndrome (Trisomy 13)**: This genetic condition can present with hypertelorism and syndactyly, but the overall symptom profile, including the metabolic issues, does not fit as well.
   - **Aicardi Syndrome**: This condition is characterized by seizures and developmental delays, but the specific combination of symptoms, particularly the facial features and metabolic issues, does not align perfectly.
   - **Kleefstra Syndrome**: This syndrome includes intellectual disability and some dysmorphic features, but the specific combination of symptoms and the metabolic profile suggest a different diagnosis.

3. **Additional Tests**: 
   - Genetic testing for Smith-Lemli-Opitz syndrome would be crucial, particularly looking for mutations in the DHCR7 gene.
   - A metabolic panel to further assess cholesterol levels and other metabolites.
   - Imaging studies (like MRI) to evaluate brain structure, especially given the seizures and developmental delays.
   - Audiological assessment to confirm the degree of hearing impairment.

Overall, the combination of symptoms strongly suggests a diagnosis of Smith-Lemli-Opitz syndrome, but further testing is necessary to confirm this and rule out other potential conditions.
</thinking>

<top5> 
+1 Smith-Lemli-Opitz Syndrome: This condition is characterized by hypertelorism, anteverted nares, syndactyly, intellectual disability, and metabolic abnormalities (elevated 7-dehydrocholesterol, hypocholesterolemia). Key symptoms not reported include congenital heart defects. 
+2 Cornelia de Lange Syndrome: This syndrome can present with similar facial features and developmental delays, but does not typically include the specific metabolic abnormalities seen here. Key symptoms not reported include limb malformations. 
+3 Patau Syndrome (Trisomy 13): This genetic condition can present with hypertelorism and syndactyly, but the overall symptom profile, including metabolic issues, does not fit as well. Key symptoms not reported include cleft lip/palate. 
+4 Aicardi Syndrome: Characterized by seizures and developmental delays, but the specific combination of symptoms",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia: This condition is characterized by metabolic acidosis, elevated methylmalonic acid levels, and neurological symptoms. The patient shows decreased methylmalonyl-CoA mutase activity and methylmalonic aciduria, which are consistent with this diagnosis. Key symptoms not reported include specific neurological deficits or seizures.

+2 Urea cycle disorder: The presence of hyperammonemia, metabolic acidosis, and failure to thrive suggests a possible urea cycle disorder. The patient’s symptoms align with this condition, particularly the neurological impact of elevated ammonia levels. Key symptoms not reported may include episodic vomiting or lethargy.

+3 Organic acidemia: The combination of metabolic acidosis, increased circulating lactate, and elevated urinary carboxylic acids suggests an organic acidemia. The patient's symptoms of failure to thrive and developmental delays are consistent with this diagnosis. Key symptoms not reported may include specific metabolic crises or acute decompensation episodes.

+4 Glycine encephalopathy: The presence of hyperglycinemia and neurological symptoms such as delayed speech and intellectual disability could indicate glycine encephalopathy. The patient’s symptoms align with this condition, particularly the hypotonia and developmental delays. Key symptoms not reported may include seizures or abnormal movements.

+5 Chronic kidney disease: The patient’s acute kidney injury, elevated creatinine, and chronic kidney disease symptoms suggest renal involvement. The systemic effects of kidney dysfunction could contribute to the overall clinical picture. Key symptoms not reported may include hypertension or electrolyte imbalances.",Hereditary metabolic disorders
[],"+1 Pyrimidine Metabolism Disorder: This aligns with the abnormal circulating pyrimidine concentration and uraciluria. Key symptoms not reported include specific neurological deficits or developmental delays.
+2 Orotic Aciduria: A specific type of pyrimidine metabolism disorder that could explain the symptoms and biochemical findings. Key symptoms not reported include growth retardation.
+3 Mitochondrial Disorder: Could explain ataxia and hypotonia, but less likely due to the specific biochemical findings. Key symptoms not reported include exercise intolerance or seizures.
+4 Congenital Disorders of Glycosylation: May present with hypotonia and neurological symptoms, but the biochemical findings do not match well. Key symptoms not reported include dysmorphic features or organ dysfunction.
+5 Neurodegenerative Disorder: Could explain ataxia and hypotonia, but the biochemical findings are not consistent. Key symptoms not reported include progressive weakness or cognitive decline.",Hereditary metabolic disorders
['Isovaleric acidemia'],"+1 Urea Cycle Disorders: Hyperammonemia, death in infancy, abnormality of prenatal development. Key symptoms not reported: Specific enzyme deficiencies (e.g., OTC deficiency).
+2 Non-ketotic Hyperglycinemia: Abnormal circulating glycine concentration, death in infancy. Key symptoms not reported: Neurological symptoms (e.g., seizures).
+3 Carnitine Transport Defect: Abnormal circulating carnitine concentration, death in infancy. Key symptoms not reported: Muscle weakness or cardiomyopathy.
+4 Organic Acidemias: Abnormality of prenatal development, death in childhood. Key symptoms not reported: Specific organic acid elevations in urine.
+5 Mitochondrial Disorders: Abnormality of prenatal development, death in infancy. Key symptoms not reported: Exercise intolerance or lactic acidosis.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic acidemia: Elevated urinary carboxylic acid levels and seizures are consistent with this diagnosis. Key symptoms not reported may include metabolic acidosis or specific organic acid profiles in urine.
+2 Mitochondrial disorder: Generalized hypotonia and seizures align with this condition. Key symptoms not reported may include exercise intolerance or specific neurological deficits.
+3 Urea cycle disorder: Seizures and hypotonia could fit, but the elevated urinary carboxylic acid is less typical. Key symptoms not reported may include hyperammonemia or altered mental status.
+4 Genetic syndromes (e.g., Zellweger syndrome): Hypotonia, seizures, and infant mortality are consistent. Key symptoms not reported may include dysmorphic features or liver dysfunction.
+5 Neuromuscular disorder: Generalized hypotonia and seizures could suggest this, but elevated urinary carboxylic acid is atypical. Key symptoms not reported may include muscle weakness or atrophy.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): Symptoms consistent include decreased 3-hydroxyacyl-CoA dehydrogenase level and potential for death in infancy. Key symptoms not reported include hypoglycemia and episodes of metabolic crisis.
+2 Carnitine Palmitoyltransferase Deficiency: Symptoms consistent include decreased plasma free carnitine and delayed development. Key symptoms not reported include muscle weakness and cardiomyopathy.
+3 Mitochondrial Disorders: Symptoms consistent include delayed speech and language development and potential for early mortality. Key symptoms not reported include exercise intolerance and seizures.
+4 Organic Acidemias: Symptoms consistent include developmental delays and metabolic issues. Key symptoms not reported include acidosis and specific metabolic crisis episodes.
+5 Urea Cycle Disorders: Symptoms consistent include developmental delays. Key symptoms not reported include hyperammonemia and neurological symptoms during metabolic crises.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hypervalinemia, hyperleucinemia, hyperisoleucinemia, seizures, and body odor. Key symptoms not reported include acute metabolic crises or lethargy during episodes.
+2 Urea Cycle Disorders: Symptoms consistent include metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and specific neurological deficits.
+3 Non-ketotic Hyperglycinemia: Symptoms consistent include seizures and hypotonia. Key symptoms not reported include characteristic EEG findings and specific metabolic derangements.
+4 Spinal Muscular Atrophy (SMA): Symptoms consistent include spastic diplegia and motor delay. Key symptoms not reported include progressive muscle weakness and atrophy.
+5 Organic Acidemias: Symptoms consistent include metabolic acidosis and neurological symptoms. Key symptoms not reported include specific organic acid elevations in urine or blood.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, elevated blood urea nitrogen, and psychosis. Key symptoms not reported may include vomiting and lethargy during metabolic crises. 
+2 Organic Acidemia: Symptoms consistent include hyperglycinemia, elevated urinary carboxylic acids, and intellectual disability. Key symptoms not reported may include metabolic acidosis and developmental delays. 
+3 Maple Syrup Urine Disease: Symptoms consistent include intellectual disability and potential metabolic derangements. Key symptoms not reported may include characteristic sweet-smelling urine and feeding difficulties. 
+4 Cerebral Creatine Deficiency Syndrome: Symptoms consistent include elevated creatinine concentration and intellectual disability. Key symptoms not reported may include seizures and developmental regression. 
+5 Mitochondrial Disorder: Symptoms consistent include cerebral atrophy, osteoporosis, and kyphoscoliosis. Key symptoms not reported may include exercise intolerance and myopathy.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric aciduria: This diagnosis is directly supported by the presence of L-2-hydroxyglutaric aciduria and aligns with the symptoms of intellectual disability, seizures, ataxia, and tremor. Key symptoms not reported include specific behavioral changes or regression in skills. 
+2 Glutaric aciduria type I: This condition can present with similar neurological symptoms, including seizures and developmental delays. Key symptoms not reported include specific metabolic crises or movement disorders. 
+3 Mitochondrial disorders: These can lead to seizures and developmental delays, but the specific metabolic marker suggests a more focused diagnosis. Key symptoms not reported include muscle weakness or exercise intolerance. 
+4 Batten disease: This neurodegenerative disorder can cause seizures and intellectual disability, but typically has a later onset and additional symptoms like vision loss. Key symptoms not reported include visual impairment or progressive neurological decline. 
+5 Aicardi syndrome: This genetic disorder can cause seizures and developmental delays, but is more specific to females and has additional characteristic features. Key symptoms not reported include agenesis of the corpus callosum or specific eye abnormalities.",Hereditary metabolic disorders
['Canavan disease'],"+1: Urea Cycle Disorder: Symptoms include motor delay and abnormal amino acid levels. Key symptoms not reported include hyperammonemia and lethargy. 
+2: Spinal Muscular Atrophy (SMA): Symptoms include motor delay and early death. Key symptoms not reported include muscle weakness and atrophy. 
+3: Mitochondrial Disorder: Symptoms include motor delay and early death. Key symptoms not reported include developmental regression and seizures. 
+4: Maple Syrup Urine Disease (MSUD): Symptoms include motor delay and abnormal amino acid levels. Key symptoms not reported include sweet-smelling urine and neurological decline. 
+5: Phenylketonuria (PKU): Symptoms include motor delay and abnormal amino acid levels. Key symptoms not reported include intellectual disability and seizures if untreated.",Hereditary metabolic disorders
['Citrullinemia type I'],"+1 Citrullinemia: Consistent with elevated plasma citrulline and hyperammonemia. Key symptoms not reported include neurological symptoms or developmental delays.
+2 Ornithine transcarbamylase deficiency: Consistent with hyperammonemia and can present with elevated citrulline. Key symptoms not reported include specific neurological symptoms or seizures.
+3 Urea cycle disorder: General category that fits the hyperammonemia and bilirubin elevation. Key symptoms not reported include specific metabolic crisis episodes.
+4 Liver disease: Increased total bilirubin suggests liver involvement. Key symptoms not reported include jaundice or abdominal swelling.
+5 Other metabolic disorders: Such as galactosemia or tyrosinemia, which can present with similar symptoms. Key symptoms not reported include specific dietary intolerances or other metabolic derangements.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, metabolic acidosis, lethargy, and hepatomegaly. Key symptoms not reported include specific amino acid imbalances.
+2 Organic Acidemia (3-Methylglutaconic Aciduria): Symptoms consistent include 3-methylglutaric aciduria, vomiting, diarrhea, and lethargy. Key symptoms not reported include specific neurological symptoms.
+3 Fatty Acid Oxidation Disorder: Symptoms consistent include hypoglycemia, lethargy, and hepatomegaly. Key symptoms not reported include episodes of hypoketotic hypoglycemia.
+4 Mitochondrial Disorder: Symptoms consistent include lethargy and recurrent infections. Key symptoms not reported include exercise intolerance or myopathy.
+5 Glycogen Storage Disease: Symptoms consistent include hypoglycemia and hepatomegaly. Key symptoms not reported include muscle weakness or cardiomyopathy.",Hereditary metabolic disorders
['Cystinuria'],"+1 Genetic syndrome (e.g., Niemann-Pick disease): Symptoms consistent include splenomegaly and seizures. Key symptoms not reported may include developmental delays and hepatomegaly.
+2 Metabolic disorder (e.g., urea cycle disorder): Symptoms consistent include seizures and potential respiratory insufficiency due to metabolic crisis. Key symptoms not reported may include vomiting and lethargy.
+3 Infectious disease (e.g., congenital infections like toxoplasmosis): Symptoms consistent include seizures and splenomegaly. Key symptoms not reported may include rash or other systemic signs of infection.
+4 Neurodegenerative disorder (e.g., Batten disease): Symptoms consistent include seizures and respiratory insufficiency. Key symptoms not reported may include vision loss and cognitive decline.
+5 Hemolytic anemia: Symptoms consistent include splenomegaly and potential seizures due to severe anemia. Key symptoms not reported may include jaundice and fatigue.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia: Symptoms consistent include methylmalonic aciduria, intellectual disability, motor delay, and generalized hypotonia. Key symptoms not reported may include metabolic acidosis and developmental regression. 
+2 Urea cycle disorder: Symptoms consistent include hyperammonemia, vomiting, and increased blood urea nitrogen. Key symptoms not reported may include lethargy and seizures. 
+3 Maple syrup urine disease: Symptoms consistent include hypervalinemia, feeding difficulties, and neurological impairment. Key symptoms not reported may include characteristic sweet-smelling urine and acute metabolic crises. 
+4 Organic acidemia: Symptoms consistent include metabolic derangements such as hypoproteinemia and abnormal amino acid concentrations. Key symptoms not reported may include failure to thrive and metabolic acidosis. 
+5 Carnitine deficiency: Symptoms consistent include abnormal circulating carnitine concentration and generalized hypotonia. Key symptoms not reported may include muscle weakness and cardiomyopathy.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: Symptoms include hypertyrosinemia and potential liver dysfunction leading to early death. Key symptoms not reported include liver failure signs such as jaundice or abdominal pain. 
+2 Phenylketonuria (PKU): Characterized by hyperphenylalaninemia. Key symptoms not reported include developmental delays or neurological symptoms. 
+3 Maple Syrup Urine Disease (MSUD): Elevated branched-chain amino acids could explain the symptoms. Key symptoms not reported include neurological impairment or characteristic sweet-smelling urine. 
+4 Organic Acidemia: Elevated urinary carboxylic acids suggest this. Key symptoms not reported include metabolic acidosis or failure to thrive. 
+5 Combined Immunodeficiency: Recurrent viral infections suggest this. Key symptoms not reported include opportunistic infections or failure to thrive.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and intellectual disability. Key symptoms not reported include seizures and behavioral issues. 
+2 Tyrosinemia (Type I): Symptoms consistent include hypertyrosinemia and potential intellectual disability. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Bardet-Biedl Syndrome: Symptoms consistent include obesity and intellectual disability. Key symptoms not reported include polydactyly and retinal degeneration. 
+4 Smith-Lemli-Opitz Syndrome: Symptoms consistent include intellectual disability and possible strabismus. Key symptoms not reported include dysmorphic features and congenital heart defects. 
+5 Alkaptonuria: Symptoms consistent include metabolic abnormalities. Key symptoms not reported include dark urine and arthritis in adulthood.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder (OTC deficiency): Symptoms include hyperammonemia, orotic aciduria, vomiting, and abnormal bleeding. Key symptoms not reported may include neurological symptoms such as lethargy or seizures.
+2 Citrullinemia: Symptoms include hyperammonemia and vomiting. Orotic aciduria is also present, but abnormal bleeding is less common. Key symptoms not reported may include developmental delays or neurological issues.
+3 Hemophilia: Symptoms include abnormal bleeding and coagulation issues. However, it does not typically present with hyperammonemia or orotic aciduria. Key symptoms not reported may include joint pain or swelling.
+4 Liver Disease: Symptoms include hyperammonemia and abnormal bleeding. However, orotic aciduria is not typically associated with liver disease. Key symptoms not reported may include jaundice or abdominal pain.
+5 Mitochondrial Disorder: Symptoms may include vomiting and neurological symptoms. However, hyperammonemia and orotic aciduria are not typical. Key symptoms not reported may include muscle weakness or exercise intolerance.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric acidemia: Symptoms consistent include intellectual disability, generalized hypotonia, hyperreflexia, hyperammonemia, abnormal cerebral morphology, and abnormal myelination. Key symptoms not reported include seizures, which can occur in some cases. 
+2 Urea cycle disorder: Symptoms consistent include hyperammonemia and intellectual disability. Key symptoms not reported include episodic vomiting and lethargy, which are common during hyperammonemic crises. 
+3 Other organic acidemia: Symptoms consistent include hyperammonemia and neurological impairment. Key symptoms not reported may include metabolic acidosis or specific organic acid profiles in urine. 
+4 Peroxisomal disorders: Symptoms consistent include hypotonia and developmental delay. Key symptoms not reported include seizures and specific dysmorphic features. 
+5 Genetic syndromes (e.g., 22q11.2 deletion syndrome): Symptoms consistent include intellectual disability and hypotonia. Key symptoms not reported include congenital heart defects or specific facial features.",Hereditary metabolic disorders
['PMM2-CDG'],"+1: Joubert Syndrome: Symptoms consistent include ataxia, intellectual disability, and cerebellar agenesis. Key symptoms not reported may include eye movement abnormalities and breathing irregularities. 
+2: Mitochondrial Disease: Symptoms consistent include intellectual disability and ataxia. Key symptoms not reported may include muscle weakness and seizures. 
+3: Cerebellar Degeneration: Symptoms consistent include ataxia and cerebellar atrophy. Key symptoms not reported may include progressive loss of motor skills. 
+4: Moyamoya Disease: Symptoms consistent include stroke-like episodes and potential cognitive impairment. Key symptoms not reported may include headaches and transient ischemic attacks. 
+5: Metachromatic Leukodystrophy: Symptoms consistent include intellectual disability and ataxia. Key symptoms not reported may include loss of motor skills and sensory deficits.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia. Key symptoms not reported include neurological impairment or developmental delays.
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and neonatal death. Key symptoms not reported include liver dysfunction or renal issues.
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include severe metabolic crises. Key symptoms not reported include characteristic sweet-smelling urine or neurological symptoms.
+4 Urea Cycle Disorders: Symptoms consistent include metabolic disturbances leading to neonatal death. Key symptoms not reported include hyperammonemia or specific amino acid imbalances.
+5 Combined Metabolic Disorders: Symptoms consistent include both hyperphenylalaninemia and hypertyrosinemia. Key symptoms not reported include specific clinical features of individual disorders involved.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, lethargy, seizures, and intellectual disability. Key symptoms not reported may include specific behavioral changes or episodes of confusion. 
+2 Organic Acidemia (e.g., Propionic Acidemia): Symptoms consistent include increased circulating lactate, vomiting, lethargy, and seizures. Key symptoms not reported may include metabolic acidosis or specific metabolic crises. 
+3 Mitochondrial Disorder: Symptoms consistent include lethargy, motor delay, seizures, and recurrent infections. Key symptoms not reported may include exercise intolerance or specific organ involvement (e.g., cardiomyopathy). 
+4 Glycine Encephalopathy: Symptoms consistent include hyperglycinemia, seizures, lethargy, and developmental delays. Key symptoms not reported may include specific neurological deficits or abnormal movements. 
+5 Tyrosinemia: Symptoms consistent include hypertyrosinemia, lethargy, and developmental delays. Key symptoms not reported may include liver dysfunction or specific skin manifestations.",Hereditary metabolic disorders
['Wilson disease'],"+1 Wilson's disease: Elevated hepatic transaminases, decreased ceruloplasmin concentration. Key symptoms not reported: Kayser-Fleischer rings, neurological symptoms. 
+2 Menkes disease: Decreased circulating copper concentration, death in adolescence. Key symptoms not reported: Kinky hair, developmental delays. 
+3 Primary biliary cholangitis: Elevated hepatic transaminases, polydipsia (potentially due to liver dysfunction). Key symptoms not reported: Fatigue, pruritus, jaundice. 
+4 Autoimmune hepatitis: Elevated hepatic transaminases, polydipsia (potentially due to liver dysfunction). Key symptoms not reported: Fatigue, joint pain, other autoimmune symptoms. 
+5 Copper deficiency: Decreased circulating copper concentration, decreased ceruloplasmin concentration. Key symptoms not reported: Anemia, bone abnormalities, neurological symptoms.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder: This is supported by hyperglutaminemia and orotic aciduria, along with neurological symptoms like seizures and lethargy. Key symptoms not reported include hyperammonemia.
+2 Amino Acid Metabolism Disorder: The presence of seizures and hypotonia aligns with this category, but the specific metabolic findings are more indicative of a urea cycle disorder. Key symptoms not reported may include specific metabolic crises.
+3 Mitochondrial Disorder: Seizures and hypotonia can occur, but the metabolic findings are less typical. Key symptoms not reported may include exercise intolerance or lactic acidosis.
+4 Congenital Infection: Neurological symptoms and hypotonia could be present, but the metabolic abnormalities do not fit. Key symptoms not reported may include other systemic signs of infection.
+5 Neurodegenerative Disorder: While lethargy and hypotonia are present, the metabolic abnormalities are not characteristic. Key symptoms not reported may include progressive weakness or developmental delays.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: Symptoms consistent include hypergalactosemia, feeding difficulties, and developmental delays. Key symptoms not reported include liver dysfunction and cataracts, which are common in untreated cases. 
+2 Smith-Lemli-Opitz Syndrome: Symptoms consistent include microcephaly, intellectual disability, and motor delay. Key symptoms not reported include characteristic facial features and congenital anomalies. 
+3 Phenylketonuria (PKU): Symptoms consistent include intellectual disability and developmental delays. Key symptoms not reported include a musty odor in urine and skin rashes. 
+4 Mucopolysaccharidosis: Symptoms consistent include developmental delays, hypotonia, and obesity. Key symptoms not reported include skeletal abnormalities and coarse facial features. 
+5 Congenital Hypothyroidism: Symptoms consistent include developmental delays and hypotonia. Key symptoms not reported include dry skin, constipation, and a large fontanelle.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Prader-Willi Syndrome: This condition is consistent with obesity and abnormal foot morphology. Hyperammonemia is not typical but can occur in metabolic disturbances. Key symptoms not reported include developmental delays and hypotonia. 
+2 Urea Cycle Disorder: Hyperammonemia is a hallmark of this disorder, and abnormal foot morphology may be present in some cases. Obesity is not a classic symptom. Key symptoms not reported include neurological symptoms or episodes of confusion. 
+3 Glycogen Storage Disease: Obesity can be a feature, and some types may present with metabolic issues. However, hyperammonemia is not common. Key symptoms not reported include exercise intolerance or muscle weakness. 
+4 Congenital Disorders of Glycosylation: This can lead to obesity and developmental issues, but hyperammonemia is less common. Key symptoms not reported include failure to thrive or organ dysfunction. 
+5 Metabolic Syndrome: While obesity is a key feature, the combination of hyperammonemia and abnormal foot morphology does not strongly align with this diagnosis. Key symptoms not reported include insulin resistance or hypertension.",Hereditary metabolic disorders
['Canavan disease'],"+1 Urea Cycle Disorder: Symptoms consistent include abnormal circulating aspartate family amino acid concentration and feeding difficulties. Key symptoms not reported include acute metabolic crises and lethargy.
+2 Krabbe Disease: Symptoms consistent include abnormal myelination and feeding difficulties. Key symptoms not reported include severe neurological decline and hypotonia.
+3 Aspartylglycosaminuria: Symptoms consistent include abnormal circulating aspartate family amino acid concentration. Key symptoms not reported include developmental delays and cognitive impairment.
+4 Maple Syrup Urine Disease: Symptoms consistent include feeding difficulties. Key symptoms not reported include metabolic crises and neurological symptoms like lethargy or seizures.
+5 Phenylketonuria (PKU): Symptoms consistent include hyperactivity and feeding difficulties. Key symptoms not reported include intellectual disability and seizures if untreated.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia and can lead to severe developmental issues and death in infancy if untreated. Key symptoms not reported include neurological deficits if the condition progresses untreated.

+2 Congenital Heart Defects: These can lead to neonatal death and may be associated with developmental abnormalities. Key symptoms not reported include cyanosis or difficulty breathing in the newborn.

+3 Metabolic Disorders (e.g., Organic Acidemias): These can present with similar symptoms, including neonatal death and developmental issues. Key symptoms not reported include vomiting, lethargy, or metabolic crises.

+4 Genetic Syndromes (e.g., Smith-Lemli-Opitz syndrome): These can cause both developmental abnormalities and metabolic issues. Key symptoms not reported include distinctive physical features or other systemic anomalies.

+5 Infections or Environmental Factors: Conditions like TORCH infections could lead to developmental issues and neonatal death. Key symptoms not reported include maternal illness during pregnancy or specific signs of infection in the newborn.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and delayed speech and language development. Key symptoms not reported include intellectual disability and seizures. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and developmental delays. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include developmental delays and metabolic abnormalities. Key symptoms not reported include characteristic sweet-smelling urine and potential neurological crises. 
+4 Mitochondrial Disorder: Symptoms consistent include developmental delays and early mortality. Key symptoms not reported include muscle weakness and exercise intolerance. 
+5 Urea Cycle Disorder: Symptoms consistent include developmental delays and metabolic disturbances. Key symptoms not reported include hyperammonemia and potential acute neurological symptoms.",Hereditary metabolic disorders
[],"+1 Congenital Heart Disease Syndrome: Symptoms consistent include ventricular septal defect, cardiomyopathy, and pulmonic stenosis. Key symptoms not reported may include facial dysmorphism or other congenital anomalies.
+2 Noonan Syndrome: Symptoms consistent include cardiac defects, hypotonia, and nephritis. Key symptoms not reported may include short stature or developmental delays.
+3 Turner Syndrome: Symptoms consistent include cardiac defects and hypotonia. Key symptoms not reported may include short stature and absence of secondary sexual characteristics.
+4 Down Syndrome: Symptoms consistent include hypotonia and potential cardiac defects. Key symptoms not reported may include characteristic facial features and developmental delays.
+5 Mitochondrial Disorder: Symptoms consistent include hypotonia and potential nephritis. Key symptoms not reported may include exercise intolerance or neurological symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and can lead to neurological symptoms. Key symptoms not reported include liver dysfunction and failure.
+2 Phenylketonuria (PKU): Hyperphenylalaninemia aligns with this diagnosis, but the absence of dietary management history and the presence of neurological symptoms suggest a more severe condition. Key symptoms not reported include developmental delays.
+3 Spinal Muscular Atrophy (SMA): The spasticity and hyperreflexia are consistent with this diagnosis, but it does not explain the metabolic abnormalities. Key symptoms not reported include muscle weakness and atrophy.
+4 Severe Combined Immunodeficiency (SCID): Recurrent viral infections suggest this diagnosis, but it does not account for the neurological symptoms or metabolic issues. Key symptoms not reported include failure to thrive and chronic diarrhea.
+5 Urea Cycle Disorder: While this could lead to neurological symptoms, the specific metabolic markers do not support this diagnosis. Key symptoms not reported include vomiting and lethargy during metabolic crises.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase I Deficiency: This condition is characterized by abnormal carnitine levels and can lead to severe metabolic crises and death in infancy. Key symptoms not reported include hypoglycemia and lethargy.

+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This metabolic disorder can cause abnormal carnitine levels and is associated with sudden infant death. Key symptoms not reported include vomiting and hypoglycemia during fasting.

+3 Congenital Heart Defects: These can lead to death in infancy and may be associated with prenatal abnormalities. Key symptoms not reported include cyanosis and difficulty breathing.

+4 Mitochondrial Disorders: These can present with metabolic issues and early death, with abnormal carnitine levels suggesting dysfunction. Key symptoms not reported include muscle weakness and developmental delays.

+5 Urea Cycle Disorders: These can lead to severe metabolic crises in infancy and may present with abnormal biochemical markers. Key symptoms not reported include hyperammonemia and neurological symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia, which can lead to developmental delays and hypotonia. Key symptoms not reported include seizures and intellectual disability. 
+2 Tyrosinemia: This metabolic disorder can cause hypertyrosinemia and may lead to neurological issues and hypotonia. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease (MSUD): This condition can present with hypotonia and developmental delays, along with metabolic abnormalities. Key symptoms not reported include characteristic sweet-smelling urine and acute metabolic crises. 
+4 Urea Cycle Disorders: These can lead to hyperammonemia and developmental delays, potentially explaining the hypotonia and speech delays. Key symptoms not reported include lethargy and vomiting. 
+5 Spinal Muscular Atrophy (SMA): This genetic disorder can cause generalized hypotonia and developmental delays, but it does not typically present with metabolic abnormalities. Key symptoms not reported include muscle weakness and atrophy.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric aciduria type I: This condition is consistent with elevated glutaric acid levels, seizures, and encephalopathy. Key symptoms not reported include movement disorders and developmental delays.
+2 Primary carnitine deficiency: The decreased plasma free carnitine aligns with this diagnosis, but seizures and opisthotonus are less common. Key symptoms not reported include muscle weakness and cardiomyopathy.
+3 Organic acidemia: The elevated urinary carboxylic acid suggests a metabolic disorder, but the specific profile points more towards glutaric aciduria. Key symptoms not reported include metabolic acidosis and failure to thrive.
+4 Urea cycle disorder: While seizures and encephalopathy are present, the specific metabolic markers do not support this diagnosis. Key symptoms not reported include hyperammonemia and respiratory distress.
+5 Mitochondrial disorder: This could explain the neurological symptoms, but the specific metabolic derangements are more indicative of glutaric aciduria. Key symptoms not reported include exercise intolerance and myopathy.",Hereditary metabolic disorders
[],"+1 Urea Cycle Disorder: This condition is consistent with metabolic acidosis, hyperkalemia, seizures, and developmental delays. Key symptoms not reported include specific metabolic derangements that could be identified through blood tests.

+2 Mitochondrial Disease: Fits with hypotonia, seizures, and developmental delays. Key symptoms not reported may include specific organ dysfunction or exercise intolerance.

+3 Peroxisomal Disorders: Consistent with hypotonia, seizures, hearing impairment, and hepatomegaly. Key symptoms not reported include specific dysmorphic features or additional metabolic abnormalities.

+4 Congenital Hypothyroidism: Could explain developmental delays and hypotonia. Key symptoms not reported include goiter or other thyroid-related symptoms.

+5 Spinal Muscular Atrophy (SMA): Explains hypotonia and motor delays. Key symptoms not reported include specific muscle weakness patterns or respiratory difficulties.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Alpers-Huttenlocher syndrome: This condition is consistent with the patient's neurological decline, hepatic dysfunction, and early mortality. Key symptoms not reported include seizures.
+2 Cerebrotendinous xanthomatosis: The neurological symptoms and liver disease align with this diagnosis, but the absence of xanthomas is a notable missing symptom.
+3 Kearns-Sayre syndrome: The ataxia and strabismus fit, but the hepatic symptoms are atypical for this mitochondrial disorder.
+4 Bardet-Biedl syndrome: While some neurological symptoms are present, the lack of obesity and renal issues makes this less likely.
+5 Aicardi syndrome: The cerebellar agenesis and neurological symptoms are relevant, but the hepatic symptoms do not fit this diagnosis.",Hereditary metabolic disorders
['Canavan disease'],"+1 Urea Cycle Disorder: This condition can lead to abnormal amino acid levels and neurological symptoms. The patient exhibits irritability, seizures, and feeding difficulties. Key symptoms not reported include hyperammonemia.

+2 Non-ketotic Hyperglycinemia: This disorder is characterized by seizures, hypotonia, and irritability, consistent with the patient's symptoms. Key symptoms not reported include specific glycine-related metabolic crises.

+3 Maple Syrup Urine Disease (MSUD): This metabolic disorder can cause neurological symptoms and feeding difficulties. The patient shows irritability and seizures. Key symptoms not reported include characteristic urine odor and developmental delay.

+4 Amino Acid Transport Defects: These can lead to abnormal amino acid levels and neurological symptoms. The patient has irritability and hypotonia. Key symptoms not reported include specific transport-related issues.

+5 Mitochondrial Disorders: These can present with a variety of neurological symptoms and metabolic derangements. The patient exhibits seizures and hypotonia. Key symptoms not reported include multi-system involvement and exercise intolerance.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and can lead to severe complications in infancy, including gastrointestinal issues. Key symptoms not reported include liver dysfunction and specific neurological symptoms.
+2 Phenylketonuria (PKU): The hyperphenylalaninemia aligns with this diagnosis, which can lead to severe outcomes if untreated. Key symptoms not reported include developmental delays and neurological impairment.
+3 Maple Syrup Urine Disease (MSUD): This could explain the combination of symptoms, particularly in infancy. Key symptoms not reported include the characteristic sweet odor of urine and neurological symptoms.
+4 Congenital Disorders of Glycosylation: These disorders can lead to developmental abnormalities and metabolic issues. Key symptoms not reported include specific growth and developmental delays.
+5 Urea Cycle Disorders: These can lead to severe metabolic crises and death in infancy. Key symptoms not reported include hyperammonemia and specific neurological symptoms.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hyperleucinemia, ataxia, and coma. Key symptoms not reported include characteristic sweet-smelling urine and acute metabolic crises. 
+2 Glutaric Acidemia Type I: Symptoms consistent include ataxia, cerebral edema, and abnormal white matter morphology. Key symptoms not reported include dystonia and specific metabolic derangements in urine organic acids. 
+3 Urea Cycle Disorder: Symptoms consistent include metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and specific patterns of amino acid abnormalities. 
+4 Mitochondrial Encephalomyopathy: Symptoms consistent include ataxia, coma, and reduced tendon reflexes. Key symptoms not reported include myopathy and exercise intolerance. 
+5 Krabbe Disease: Symptoms consistent include ataxia, cerebral edema, and death in childhood/adolescence. Key symptoms not reported include peripheral neuropathy and specific findings on nerve conduction studies.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"+1 Acute Intermittent Porphyria: Abdominal pain, elevated urinary delta-aminolevulinic acid. Key symptoms not reported: Neurological symptoms (e.g., seizures, confusion).
+2 Hereditary Coproporphyria: Abdominal pain, elevated urinary delta-aminolevulinic acid. Key symptoms not reported: Skin lesions or photosensitivity.
+3 Lead Poisoning: Abdominal pain, elevated urinary delta-aminolevulinic acid. Key symptoms not reported: Neurological deficits, anemia.
+4 Porphyria Cutanea Tarda: Abdominal pain. Key symptoms not reported: Skin lesions, photosensitivity, elevated porphyrins.
+5 Uroporphyria: Abdominal pain, elevated urinary delta-aminolevulinic acid. Key symptoms not reported: Specific skin symptoms or photosensitivity.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia: This condition is consistent with seizures, metabolic acidosis, and methylmalonic aciduria. Key symptoms not reported include developmental delays and failure to thrive. 
+2 Propionic acidemia: This condition aligns with metabolic acidosis and seizures. Key symptoms not reported include hypoglycemia and a characteristic odor in urine. 
+3 Organic acidemia: This broader category fits the metabolic acidosis and seizures but lacks specificity. Key symptoms not reported include varying degrees of developmental delay and specific organic acid profiles. 
+4 Urea cycle disorder: While it can cause metabolic acidosis and seizures, the specific mention of methylmalonic aciduria makes this less likely. Key symptoms not reported include hyperammonemia and altered mental status. 
+5 Peroxisomal disorder: This could explain seizures and metabolic issues, but the specific symptoms do not align well. Key symptoms not reported include hypotonia and dysmorphic features.",Hereditary metabolic disorders
['Alkaptonuria'],"+1 Urea Cycle Disorder: This condition can cause seizures, lethargy, and dark urine due to ammonia accumulation. Key symptoms not reported include vomiting and irritability.
+2 Mitochondrial Disease: This can lead to seizures, hypotonia, and growth delays. Key symptoms not reported include exercise intolerance and muscle weakness.
+3 Maple Syrup Urine Disease: This can present with seizures and dark urine. Key symptoms not reported include a characteristic sweet odor in urine and metabolic crises.
+4 Krabbe Disease: This can cause hypotonia, seizures, and growth delays, often leading to early death. Key symptoms not reported include irritability and developmental regression.
+5 Glycogen Storage Disease: This can lead to hypotonia, seizures, and growth delays. Key symptoms not reported include hepatomegaly and hypoglycemia.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): This condition is characterized by seizures, aminoaciduria, and elevated levels of leucine, isoleucine, and valine. Key symptoms not reported include a characteristic sweet odor of the urine. 
+2 Urea Cycle Disorder: This could explain seizures and metabolic disturbances, but typically presents with hyperammonemia rather than specific amino acid abnormalities. Key symptoms not reported include lethargy and vomiting. 
+3 Organic Acidemia: This could account for seizures and metabolic derangements, but would usually present with different patterns of amino acid abnormalities. Key symptoms not reported include metabolic acidosis and failure to thrive. 
+4 Phenylketonuria (PKU): While this condition involves aminoaciduria and can lead to neurological symptoms, it primarily affects phenylalanine metabolism rather than branched-chain amino acids. Key symptoms not reported include intellectual disability and a musty odor. 
+5 Glutaric Acidemia: This condition can cause seizures and metabolic issues, but typically presents with different metabolic derangements and is associated with specific neurological symptoms. Key symptoms not reported include dystonia and macrocephaly.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase II Deficiency (CPT II Deficiency): Symptoms include hypoglycemia, cardiomegaly, increased lactate, and dicarboxylic aciduria. Key symptoms not reported include muscle weakness or exercise intolerance. 
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): Symptoms include hypoglycemia, increased lactate, and dicarboxylic aciduria. Key symptoms not reported include vomiting and lethargy during fasting. 
+3 Mitochondrial Myopathy: Symptoms include cardiomegaly and increased lactate. Key symptoms not reported include muscle weakness and exercise intolerance. 
+4 Glycogen Storage Disease (GSD): Symptoms include hypoglycemia and cardiomegaly. Key symptoms not reported include hepatomegaly and growth retardation. 
+5 Lipid Storage Disorders (e.g., Wolman disease): Symptoms include hepatomegaly and cardiomyopathy. Key symptoms not reported include diarrhea and failure to thrive.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Glutaric aciduria type I: Symptoms consistent with this diagnosis include glutaric aciduria, progressive neurological deterioration, and seizures. Key symptoms not reported include movement disorders or dystonia, which are common in this condition. 
+2 3-Methylglutaric aciduria: Symptoms consistent with this diagnosis include 3-methylglutaric aciduria, hypoglycemia, and seizures. Key symptoms not reported include metabolic crises triggered by fasting or illness. 
+3 Non-ketotic hyperglycinemia: Symptoms consistent with this diagnosis include abnormal circulating glycine concentration, lethargy, and seizures. Key symptoms not reported include hypotonia and developmental delay, which are often seen in this condition. 
+4 Fatty acid oxidation disorder (e.g., Medium-chain acyl-CoA dehydrogenase deficiency): Symptoms consistent with this diagnosis include hypoglycemia, vomiting, and lethargy. Key symptoms not reported include episodes of metabolic decompensation during fasting or illness. 
+5 Mitochondrial disorder (e.g., Mitochondrial encephalomyopathy): Symptoms consistent with this diagnosis include progressive neurological deterioration, seizures, and metabolic acidosis. Key symptoms not reported include muscle weakness or exercise intolerance, which are common in mitochondrial disorders.",Hereditary metabolic disorders
['MODY'],"+1 Insulinoma: This condition is consistent with hypoglycemia due to excess insulin production. Glycosuria may occur if there is concurrent diabetes. Key symptoms not reported include weight loss and episodes of confusion or seizures during hypoglycemic events. 
+2 Diabetes Mellitus: This can explain glycosuria and hypoglycemia if the patient is on insulin or other medications. However, the abnormal porphyrin levels are not typical. Key symptoms not reported include polyuria, polydipsia, and weight changes. 
+3 Porphyria: The abnormal porphyrin concentration aligns with this diagnosis, and some types can cause hypoglycemia. Glycosuria is less common. Key symptoms not reported include abdominal pain, photosensitivity, and neurological symptoms. 
+4 Adrenal Insufficiency: This can lead to hypoglycemia and may affect glucose metabolism, but glycosuria is not typical. Key symptoms not reported include fatigue, weight loss, and hyperpigmentation. 
+5 Renal Glycosuria: This condition explains glycosuria without hyperglycemia but does not account for hypoglycemia or abnormal porphyrin levels. Key symptoms not reported include frequent urination and possible renal issues.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia and can lead to severe developmental issues and death in infancy if untreated. Key symptoms not reported include developmental delays and neurological deficits.

+2 Congenital Heart Defects: These can lead to neonatal death and may be associated with prenatal abnormalities. Key symptoms not reported include cyanosis or difficulty breathing.

+3 Maple Syrup Urine Disease (MSUD): This metabolic disorder can present with hyperphenylalaninemia and lead to severe outcomes in infancy. Key symptoms not reported include distinctive urine odor and neurological symptoms.

+4 Urea Cycle Disorders: These can cause hyperphenylalaninemia and lead to severe metabolic crises in infancy. Key symptoms not reported include vomiting, lethargy, and seizures.

+5 Genetic Syndromes (e.g., Smith-Lemli-Opitz syndrome): These can cause developmental abnormalities and metabolic issues. Key symptoms not reported include dysmorphic features and other systemic anomalies.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Metachromatic leukodystrophy: Symptoms include macrocephaly, seizures, and developmental delays. Key symptoms not reported include specific cognitive decline and behavioral changes. 
+2 Glutaric aciduria type I: Symptoms include dystonia, seizures, and macrocephaly. Key symptoms not reported include specific metabolic crises or acute neurological events. 
+3 Aicardi syndrome: Symptoms include hydrocephalus, seizures, and developmental delays. Key symptoms not reported include the typical absence of male cases and specific eye abnormalities. 
+4 Batten disease: Symptoms include seizures, cognitive decline, and motor symptoms. Key symptoms not reported include vision loss and specific behavioral changes. 
+5 Mitochondrial encephalomyopathy: Symptoms include seizures, recurrent infections, and neurological decline. Key symptoms not reported include lactic acidosis and specific muscle weakness.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is consistent with hyperphenylalaninemia. Key symptoms not reported include intellectual disability and seizures. 
+2 Tyrosinemia: This diagnosis aligns with hypertyrosinemia and can lead to severe complications and death in infancy. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease (MSUD): This condition could explain the severe metabolic issues and early mortality. Key symptoms not reported include characteristic sweet-smelling urine and neurological decline. 
+4 Urea Cycle Disorders: These disorders could explain the metabolic crisis leading to death in infancy. Key symptoms not reported include hyperammonemia and lethargy. 
+5 Congenital Disorders of Glycosylation: This group of disorders could explain developmental issues and early mortality. Key symptoms not reported include failure to thrive and various systemic manifestations.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: This condition is consistent with hypertyrosinemia and can lead to severe complications if untreated. Key symptoms not reported include liver failure and neurological issues.

+2 Phenylketonuria (PKU): This diagnosis aligns with hyperphenylalaninemia and can cause cognitive impairment if not managed. Key symptoms not reported include developmental delays and seizures.

+3 Maple Syrup Urine Disease (MSUD): While less likely, it could explain some metabolic disturbances. Key symptoms not reported include sweet-smelling urine and neurological symptoms.

+4 Urea Cycle Disorders: These could explain elevated ammonia levels and neurological symptoms. Key symptoms not reported include lethargy and vomiting.

+5 Liver Disease: This could account for the metabolic abnormalities observed. Key symptoms not reported include jaundice and abdominal pain.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Consistent symptoms include hyperphenylalaninemia and neonatal death. Key symptoms not reported include neurological impairment if untreated.
+2 Tyrosinemia: Consistent symptoms include hypertyrosinemia and elevated urinary carboxylic acid. Key symptoms not reported include liver dysfunction and failure.
+3 Maple Syrup Urine Disease (MSUD): Consistent symptoms include elevated urinary carboxylic acid. Key symptoms not reported include elevated branched-chain amino acids and neurological symptoms.
+4 Urea Cycle Disorders: Consistent symptoms include neonatal death. Key symptoms not reported include hyperammonemia and specific amino acid imbalances.
+5 Organic Acidemias: Consistent symptoms include elevated urinary carboxylic acid. Key symptoms not reported include specific metabolic crises and varying presentations based on the type of acidemia.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Hyperphenylalaninemia, abnormality of prenatal development. Key symptoms not reported: Neurological symptoms, developmental delays.
+2 Tyrosinemia: Hypertyrosinemia, death in infancy and childhood. Key symptoms not reported: Liver dysfunction, renal issues.
+3 Maple Syrup Urine Disease (MSUD): Death in infancy, potential metabolic crisis. Key symptoms not reported: Characteristic sweet-smelling urine, neurological symptoms.
+4 Urea Cycle Disorders: Abnormality of prenatal development, death in infancy. Key symptoms not reported: Hyperammonemia, neurological symptoms.
+5 Galactosemia: Death in infancy. Key symptoms not reported: Jaundice, feeding difficulties, cataracts.",Hereditary metabolic disorders
['Hereditary orotic aciduria'],"+1 Metachromatic leukodystrophy: Symptoms consistent include generalized hypotonia, lethargy, and splenomegaly. Key symptoms not reported include neurological decline and ataxia. 
+2 Urea cycle disorder: Symptoms consistent include lethargy, vomiting, and hyperglycinuria. Key symptoms not reported include hyperammonemia and seizures. 
+3 Cystinosis: Symptoms consistent include renal tubular Fanconi syndrome (cystinuria, orotic aciduria), lethargy, and growth failure. Key symptoms not reported include ocular symptoms (photophobia) and renal failure. 
+4 Niemann-Pick disease: Symptoms consistent include splenomegaly, hepatomegaly, and skin rash. Key symptoms not reported include neurological symptoms and cherry-red spot on the retina. 
+5 Glycogen storage disease: Symptoms consistent include hepatomegaly, lethargy, and feeding difficulties. Key symptoms not reported include hypoglycemia and muscle weakness.",Hereditary metabolic disorders
['Holocarboxylase synthetase deficiency'],"+1 Propionic acidemia: This condition is consistent with symptoms such as metabolic acidosis, hyperammonemia, and decreased propionyl-CoA carboxylase activity. Key symptoms not reported include developmental delays and seizures. 
+2 Methylmalonic acidemia: Symptoms like metabolic acidosis, hypotonia, and elevated urinary carboxylic acid levels align with this diagnosis. Key symptoms not reported include failure to thrive and developmental regression. 
+3 Urea cycle disorder: Hyperammonemia and metabolic acidosis are consistent with this diagnosis. Key symptoms not reported include lethargy and irritability. 
+4 Organic acidemia: The combination of metabolic acidosis, aminoaciduria, and elevated urinary carboxylic acid suggests this broad category. Key symptoms not reported include vomiting and poor feeding. 
+5 Glycine encephalopathy: The abnormal circulating glycine concentration supports this diagnosis, with symptoms like hypotonia and metabolic disturbances. Key symptoms not reported include seizures and developmental delays.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, orotic aciduria, lethargy, and ataxia. Key symptoms not reported include seizures or irritability.
+2 Ornithine Transcarbamylase Deficiency: Characterized by hyperammonemia and orotic aciduria, along with neurological symptoms. Key symptoms not reported include specific developmental delays.
+3 Citrullinemia: Presents with hyperammonemia and neurological symptoms, including lethargy and ataxia. Key symptoms not reported include failure to thrive or feeding difficulties in infancy.
+4 Argininosuccinic Aciduria: Can cause hyperammonemia and neurological symptoms, including ataxia and lethargy. Key symptoms not reported include recurrent vomiting or behavioral changes.
+5 Mitochondrial Encephalomyopathy: May present with ataxia, lethargy, and drowsiness, but typically does not feature hyperammonemia or orotic aciduria. Key symptoms not reported include muscle weakness or exercise intolerance.",Hereditary metabolic disorders
[],"+1 Ethylmalonic Encephalopathy: This condition is consistent with ethylmalonic aciduria and the history of early death. Key symptoms not reported include neurological deficits and developmental delays.
+2 Short-Chain Acyl-CoA Dehydrogenase Deficiency: This could explain the decreased enzyme levels and metabolic issues, but does not typically present with ethylmalonic aciduria. Key symptoms not reported include hypoglycemia and metabolic crises.
+3 Carnitine Palmitoyltransferase II Deficiency: This condition aligns with abnormal carnitine levels and could lead to vomiting. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness.
+4 Medium-Chain Acyl-CoA Dehydrogenase Deficiency: This could explain some metabolic derangements but does not typically present with ethylmalonic aciduria. Key symptoms not reported include episodes of hypoglycemia and lethargy.
+5 Mitochondrial Fatty Acid Oxidation Disorders: This broad category could encompass several conditions leading to the observed symptoms. Key symptoms not reported include exercise intolerance and cardiomyopathy.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz syndrome (SLOS): Symptoms consistent include low-set ears, wide nasal bridge, anteverted nares, ptosis, syndactyly, intellectual disability, motor delay, generalized hypotonia, hypocholesterolemia, and elevated 7-dehydrocholesterol. Key symptoms not reported include possible behavioral issues or specific physical anomalies associated with SLOS.
+2 Down syndrome: Symptoms consistent include low-set ears, wide nasal bridge, ptosis, and intellectual disability. Key symptoms not reported include characteristic palmar crease patterns and hypotonia at birth.
+3 Turner syndrome: Symptoms consistent include low-set ears and ptosis. Key symptoms not reported include short stature and absence of secondary sexual characteristics.
+4 Congenital adrenal hyperplasia: Symptoms consistent include hypotonia and feeding difficulties. Key symptoms not reported include ambiguous genitalia or adrenal crisis symptoms.
+5 Achondroplasia: Symptoms consistent include hypotonia and developmental delays. Key symptoms not reported include disproportionate short stature and specific skeletal abnormalities.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric aciduria: Intellectual disability, ataxia, tremor, cerebral atrophy, abnormal basal ganglia morphology, L-2-hydroxyglutaric aciduria. Key symptoms not reported: None.
+2 Glutaric aciduria type I: Intellectual disability, ataxia, tremor, cerebral atrophy, abnormal basal ganglia morphology. Key symptoms not reported: Specific metabolic findings of glutaric acid.
+3 Other organic acidemias: Intellectual disability, ataxia, tremor. Key symptoms not reported: Specific metabolic findings related to other organic acids.
+4 Mitochondrial disorders: Intellectual disability, ataxia, tremor, cerebral atrophy. Key symptoms not reported: Specific mitochondrial dysfunction symptoms.
+5 Neurodegenerative disorders: Intellectual disability, ataxia, tremor, cerebral atrophy. Key symptoms not reported: Specific lysosomal storage symptoms.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Organic Acidemia: Consistent symptoms include metabolic acidosis, dicarboxylic aciduria, and irritability. Key symptoms not reported may include specific dietary triggers or acute metabolic crises.
+2 Mitochondrial Disorder: Consistent symptoms include seizures, generalized hypotonia, and 3-methylglutaconic aciduria. Key symptoms not reported may include exercise intolerance or developmental delays.
+3 Urea Cycle Disorder: Consistent symptoms include irritability and metabolic acidosis. Key symptoms not reported may include hyperammonemia or specific neurological deficits.
+4 Peroxisomal Disorder: Consistent symptoms include hypotonia and seizures. Key symptoms not reported may include dysmorphic features or specific metabolic abnormalities.
+5 Lysosomal Storage Disorder: Consistent symptoms include hypotonia and seizures. Key symptoms not reported may include hepatosplenomegaly or specific storage material accumulation.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1: L-2-hydroxyglutaric aciduria: Symptoms consistent include L-2-hydroxyglutaric aciduria, seizures, and skin rash. Key symptoms not reported include developmental delays or intellectual disability. 
+2: Autoimmune encephalitis: Symptoms consistent include seizures, fever, and skin rash. Key symptoms not reported include cognitive changes or psychiatric symptoms. 
+3: Inflammatory bowel disease (IBD): Symptoms consistent include skin rash and elevated C-reactive protein. Key symptoms not reported include gastrointestinal symptoms such as diarrhea or abdominal pain. 
+4: Infection (e.g., viral encephalitis): Symptoms consistent include fever, seizures, and skin rash. Key symptoms not reported include altered consciousness or focal neurological deficits. 
+5: Hematological disorder (e.g., anemia of chronic disease): Symptoms consistent include decreased circulating iron concentration and elevated C-reactive protein. Key symptoms not reported include fatigue or pallor.",Hereditary metabolic disorders
['X-linked hypophosphatemia'],"+1 X-linked hypophosphatemic rickets (XLH): Symptoms consistent include hypophosphatemia, abnormal limb bone morphology, and elevated alkaline phosphatase. Key symptoms not reported include dental issues and potential growth retardation.
+2 Fanconi syndrome: Symptoms consistent include hypophosphatemia and abnormal limb bone morphology. Key symptoms not reported include aminoaciduria and glucosuria.
+3 Cystinosis: Symptoms consistent include nephritis and abnormal limb bone morphology. Key symptoms not reported include ocular symptoms and growth failure.
+4 Osteogenesis imperfecta: Symptoms consistent include abnormal limb bone morphology. Key symptoms not reported include frequent fractures and blue sclera.
+5 Hypophosphatasia: Symptoms consistent include elevated alkaline phosphatase and abnormal limb bone morphology. Key symptoms not reported include low serum phosphate and skeletal deformities.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: Hyperammonemia, delayed speech and language development, leukopenia. Key symptoms not reported: Vomiting, lethargy, or seizures during metabolic crises. 
+2 Non-ketotic Hyperglycinemia: Hyperglycinemia, hyperglycinuria, delayed speech and language development. Key symptoms not reported: Hypotonia, seizures, or developmental regression. 
+3 Organic Acidemia: Elevated urinary carboxylic acid, abnormal circulating amino acid concentrations. Key symptoms not reported: Metabolic acidosis, failure to thrive, or episodic illness. 
+4 Amino Acid Metabolism Disorder: Abnormal circulating concentrations of multiple amino acids, delayed speech and language development. Key symptoms not reported: Specific symptoms related to individual amino acid deficiencies. 
+5 Mitochondrial Disorder: Neurological decline, metabolic derangements, elevated alkaline phosphatase. Key symptoms not reported: Muscle weakness, exercise intolerance, or lactic acidosis.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Methylmalonic acidemia: This condition is consistent with the patient's symptoms of delayed speech and language development, generalized hypotonia, and methylmalonic aciduria. Key symptoms not reported include episodes of metabolic crisis or acidosis. 
+2 Homocystinuria: The presence of hyperhomocystinemia aligns with this diagnosis, along with developmental delays and hypotonia. Key symptoms not reported include lens dislocation and thromboembolic events. 
+3 Organic acidemia: This category could encompass several conditions, including propionic acidemia, which aligns with hypotonia and developmental delays. Key symptoms not reported include metabolic acidosis and specific organic acid profiles. 
+4 Leukodystrophy: The abnormal cerebral white matter morphology suggests this possibility, along with developmental delays. Key symptoms not reported include progressive neurological decline and seizures. 
+5 Carnitine deficiency: The decreased plasma free carnitine supports this diagnosis, which can lead to hypotonia and developmental delays. Key symptoms not reported include muscle weakness and cardiomyopathy.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic Acidemia: Elevated urinary carboxylic acid is consistent with this diagnosis. Key symptoms not reported include metabolic acidosis and lethargy during metabolic crises. 
+2 Fatty Acid Oxidation Disorder: Elevated urinary carboxylic acid may indicate this condition. Key symptoms not reported include hypoglycemia and cardiomyopathy. 
+3 Urea Cycle Disorder: While not directly indicated by urinary findings, metabolic crises can lead to neonatal death. Key symptoms not reported include hyperammonemia and altered mental status. 
+4 Mitochondrial Disorder: Can cause severe metabolic issues in infancy. Key symptoms not reported include developmental delays and muscle weakness. 
+5 Congenital Infection: While not directly indicated by urinary findings, infections can lead to neonatal death. Key symptoms not reported include microcephaly and hearing loss.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Urea Cycle Disorder: Hyperammonemia, lethargy, drowsiness, feeding difficulties. Key symptoms not reported: Vomiting, seizures.
+2 Spinal Muscular Atrophy: Generalized hypotonia, feeding difficulties, lethargy. Key symptoms not reported: Muscle weakness, atrophy.
+3 Cerebral Palsy: Spasticity, hyperreflexia, feeding difficulties. Key symptoms not reported: Motor delays, seizures.
+4 Mitochondrial Disorder: Lethargy, hypotonia, feeding difficulties. Key symptoms not reported: Myopathy, seizures, developmental delays.
+5 Genetic Syndrome (e.g., Zellweger Spectrum Disorder): Hypotonia, feeding difficulties, lethargy. Key symptoms not reported: Facial dysmorphism, organ dysfunction.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia (MMA): Symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. Key symptoms not reported include developmental delays and failure to thrive in infancy. 
+2 Propionic Acidemia: Symptoms include metabolic acidosis and can lead to similar outcomes in infancy. However, it is characterized by propionyl-CoA accumulation rather than decreased methylmalonyl-CoA mutase activity. 
+3 Isovaleric Acidemia: Symptoms include metabolic acidosis and can present in infancy. However, it is associated with isovaleryl-CoA rather than methylmalonyl-CoA mutase deficiency. 
+4 Urea Cycle Disorder: Symptoms include metabolic acidosis and can lead to severe outcomes in infancy. However, it does not specifically relate to decreased methylmalonyl-CoA mutase activity. 
+5 Glutaric Acidemia: Symptoms include metabolic acidosis and neurological symptoms, but it is not directly related to methylmalonyl-CoA mutase activity.",Hereditary metabolic disorders
[],"+1 Galactosemia: This condition could explain the hemolytic anemia and metabolic acidosis. Key symptoms not reported include jaundice and failure to thrive.
+2 Mitochondrial myopathy: The combination of spasticity, recurrent infections, and metabolic acidosis fits this diagnosis. Key symptoms not reported include muscle weakness and exercise intolerance.
+3 Porphyria: The abnormal circulating porphyrin concentration is a strong indicator. Key symptoms not reported include photosensitivity and abdominal pain.
+4 Severe combined immunodeficiency (SCID): The recurrent viral infections suggest an immunodeficiency. Key symptoms not reported include failure to thrive and opportunistic infections.
+5 Sickle cell disease: This could explain the hemolytic anemia and increased bilirubin. Key symptoms not reported include pain crises and dactylitis.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1 Urea Cycle Disorder (Citrullinemia): Symptoms include hyperammonemia, elevated plasma citrulline, respiratory distress, apnea, and hypoxemia. Key symptoms not reported include neurological symptoms such as lethargy or seizures. 
+2 Organic Acidemia: Symptoms include metabolic acidosis, respiratory distress, and hypoxemia. Key symptoms not reported include specific organic acid levels in urine or plasma.
+3 Respiratory Distress Syndrome: Symptoms include respiratory distress, apnea, and hypoxemia. Key symptoms not reported include specific findings on chest imaging or surfactant deficiency.
+4 Sepsis: Symptoms include respiratory distress, hypoxemia, and potential metabolic derangements. Key symptoms not reported include fever or signs of infection.
+5 Congenital Heart Disease: Symptoms include hypoxemia and respiratory distress. Key symptoms not reported include cyanosis or specific heart murmur findings.",Hereditary metabolic disorders
[],"+1 Methylmalonic Acidemia (MMA): Symptoms consistent include hyperammonemia, vomiting, hypotonia, and intellectual disability. Key symptoms not reported include specific metabolic crises or episodes of metabolic decompensation.

+2 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, seizures, and coma. Key symptoms not reported include specific triggers for metabolic crises or family history of similar conditions.

+3 Organic Acidemia: Symptoms consistent include increased circulating lactate concentration and abnormal amino acid concentrations. Key symptoms not reported include specific episodes of metabolic acidosis or crises.

+4 Atransferrinemia: Symptoms consistent include anemia and leukopenia. Key symptoms not reported include iron overload symptoms or specific hematological abnormalities.

+5 Chronic Kidney Disease (CKD): Symptoms consistent include hypertension, edema, and elevated creatinine concentration. Key symptoms not reported include specific renal symptoms or history of urinary tract issues.",Hereditary metabolic disorders
['Dihydropteridine reductase deficiency'],"+1 Phenylketonuria (PKU): Symptoms include intellectual disability, seizures, and motor delay. Key symptoms not reported include a specific diet-related history or phenylalanine-related symptoms. 
+2 Tyrosinemia: Symptoms include hypertyrosinemia, seizures, motor delay, and hypotonia. Key symptoms not reported include liver dysfunction or renal issues. 
+3 Congenital Zika Syndrome: Symptoms include microcephaly, nystagmus, and developmental delays. Key symptoms not reported include specific maternal infection history during pregnancy. 
+4 Lissencephaly: Symptoms include seizures, motor delay, and hypotonia. Key symptoms not reported include specific imaging findings of lissencephaly. 
+5 Metachromatic Leukodystrophy: Symptoms include motor delay, hypotonia, and seizures. Key symptoms not reported include specific cognitive decline patterns or family history of leukodystrophy.",Hereditary metabolic disorders
[],"+1 Mitochondrial myopathy: The presence of cytochrome C oxidase-negative muscle fibers and ethylmalonic aciduria are consistent with this diagnosis. Key symptoms not reported include exercise intolerance and muscle weakness. 
+2 Organic acidemia: Ethylmalonic aciduria aligns with this diagnosis, and feeding difficulties are also consistent. Key symptoms not reported include metabolic acidosis and developmental delays. 
+3 Glycine encephalopathy (non-ketotic hyperglycinemia): Abnormal circulating glycine concentration supports this diagnosis. Key symptoms not reported include seizures and neurological deficits. 
+4 Urea cycle disorder: Feeding difficulties and metabolic derangements could suggest this condition. Key symptoms not reported include hyperammonemia and altered mental status. 
+5 Inherited metabolic disorder (e.g., fatty acid oxidation disorder): The combination of symptoms suggests this broader category. Key symptoms not reported include hypoglycemia and cardiomyopathy.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Citrullinemia: This condition is consistent with hyperammonemia, low plasma citrulline, and orotic aciduria. Key symptoms not reported include elevated citrulline levels in other cases.
+2 Ornithine transcarbamylase deficiency: This diagnosis aligns with hyperammonemia and orotic aciduria. Key symptoms not reported include elevated orotic acid levels in urine.
+3 Argininosuccinic aciduria: This condition can present with seizures and hyperammonemia, but the low citrulline makes it less likely. Key symptoms not reported include elevated argininosuccinic acid levels.
+4 Urea cycle disorders (general): This encompasses various conditions leading to hyperammonemia and neurological symptoms. Key symptoms not reported include specific amino acid imbalances.
+5 Mitochondrial disorders: While less likely, some mitochondrial disorders can present with similar symptoms. Key symptoms not reported include muscle weakness or exercise intolerance.",Hereditary metabolic disorders
['Canavan disease'],"+1 Non-ketotic hyperglycinemia (NKH): Hyperammonemia, seizures, abnormal circulating glycine concentration. Key symptoms not reported: Developmental delays, hypotonia. 
+2 Urea cycle disorders (UCDs): Hyperammonemia, seizures, aminoaciduria. Key symptoms not reported: Specific amino acid imbalances depending on the type of UCD. 
+3 Maple syrup urine disease (MSUD): Aminoaciduria, neurological symptoms. Key symptoms not reported: Specific odor of urine, metabolic crises. 
+4 Phenylketonuria (PKU): Neurological symptoms, aminoaciduria. Key symptoms not reported: Eczema, lighter skin pigmentation. 
+5 Argininosuccinic aciduria: Hyperammonemia, seizures, aminoaciduria. Key symptoms not reported: Liver dysfunction, developmental delays.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Seizures, hypervalinemia, hyperleucinemia, hyperisoleucinemia. Key symptoms not reported include maple syrup odor in urine.
+2 Urea Cycle Disorder: Seizures, respiratory insufficiency, feeding difficulties. Key symptoms not reported include hyperammonemia.
+3 Mitochondrial Disorder: Seizures, respiratory insufficiency, opisthotonus. Key symptoms not reported include developmental delays or muscle weakness.
+4 Phenylketonuria (PKU): Seizures, hyperleucinemia. Key symptoms not reported include intellectual disability or a musty odor in urine.
+5 Central Nervous System Infection (e.g., meningitis): Seizures, respiratory insufficiency, opisthotonus, sepsis. Key symptoms not reported include fever or altered consciousness.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase II Deficiency: This condition is consistent with the abnormal circulating carnitine concentration and decreased 3-hydroxyacyl-CoA dehydrogenase level. Key symptoms not reported include episodes of hypoglycemia and muscle weakness.
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): The decreased 3-hydroxyacyl-CoA dehydrogenase level aligns with this diagnosis, and the history of death in infancy is consistent. Key symptoms not reported include vomiting and lethargy during metabolic crises.
+3 Mitochondrial Disorders: The combination of obesity and metabolic dysfunction could suggest a mitochondrial disorder. Key symptoms not reported include exercise intolerance and neurological symptoms.
+4 Congenital Disorders of Glycosylation: This could explain the obesity and developmental issues, but the metabolic markers are less specific. Key symptoms not reported include hypotonia and organ dysfunction.
+5 Prader-Willi Syndrome: This genetic disorder is characterized by obesity and developmental delays, but it does not typically present with the metabolic abnormalities noted. Key symptoms not reported include hypogonadism and behavioral issues.",Hereditary metabolic disorders
['Phenylketonuria'],"+1: Leukodystrophy: Symptoms consistent include abnormal cerebral white matter morphology, intellectual disability, motor delay, and seizures. Key symptoms not reported may include specific motor deficits or cognitive decline patterns. 
+2: Phenylketonuria (PKU): Symptoms consistent include intellectual disability, motor delay, and hyperphenylalaninemia. Key symptoms not reported may include behavioral issues or skin rashes. 
+3: Tyrosinemia: Symptoms consistent include hypertyrosinemia, intellectual disability, and seizures. Key symptoms not reported may include liver dysfunction or renal issues. 
+4: Glutaric aciduria type I: Symptoms consistent include intellectual disability, motor delay, and seizures. Key symptoms not reported may include movement disorders or metabolic crises. 
+5: Mitochondrial disorder: Symptoms consistent include intellectual disability, seizures, motor delay, and dyskinesia. Key symptoms not reported may include exercise intolerance or myopathy.",Hereditary metabolic disorders
['Wilson disease'],"+1 Wilson's disease: Symptoms include hepatomegaly, splenomegaly, elevated hepatic transaminases, decreased ceruloplasmin, and increased urinary copper. Key symptoms not reported include neurological symptoms (e.g., tremors, psychiatric disturbances).

+2 Menkes disease: Symptoms include hypotonia, copper deficiency, and liver dysfunction. Key symptoms not reported include kinky hair and developmental delays.

+3 Copper overload syndromes (e.g., primary biliary cholangitis): Symptoms include hepatomegaly and elevated transaminases. Key symptoms not reported include pruritus and jaundice.

+4 Alpha-1 antitrypsin deficiency: Symptoms include liver disease and hypotonia. Key symptoms not reported include respiratory issues and skin problems.

+5 Tyrosinemia: Symptoms include liver dysfunction and hypotonia. Key symptoms not reported include renal tubular dysfunction and specific metabolic derangements in tyrosine metabolism.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Dandy-Walker Malformation: Symptoms consistent include ataxia, hypotonia, and potential intellectual disability. Key symptoms not reported include cystic enlargement of the fourth ventricle. 
+2 Aicardi Syndrome: Symptoms consistent include intellectual disability and strabismus. Key symptoms not reported include seizures and absence of the corpus callosum. 
+3 Miller-Dieker Syndrome: Symptoms consistent include intellectual disability and abnormal facial shape. Key symptoms not reported include lissencephaly and seizures. 
+4 Pontocerebellar Hypoplasia: Symptoms consistent include ataxia and hypotonia. Key symptoms not reported include specific pontine abnormalities. 
+5 Cerebellar Agenesis: Symptoms consistent include ataxia, hypotonia, and intellectual disability. Key symptoms not reported include specific craniofacial dysmorphism.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and potential neurological impairment. Key symptoms not reported include developmental delays and seizures. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and potential for severe liver and kidney issues. Key symptoms not reported include failure to thrive and liver dysfunction. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include metabolic derangement and potential for neurological decline. Key symptoms not reported include characteristic sweet-smelling urine and acute metabolic crises. 
+4 Urea Cycle Disorder: Symptoms consistent include metabolic abnormalities and potential for neurological symptoms. Key symptoms not reported include hyperammonemia and lethargy. 
+5 Galactosemia: Symptoms consistent include metabolic derangement and potential for early mortality. Key symptoms not reported include jaundice and feeding difficulties in infancy.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms consistent include macrocephaly, generalized hypotonia, abnormal cerebral morphology, and death in infancy. Key symptoms not reported may include episodes of metabolic crisis or movement disorders. 
+2 Mitochondrial Myopathy: Symptoms consistent include generalized hypotonia and increased circulating lactate concentration. Key symptoms not reported may include muscle weakness or exercise intolerance. 
+3 Maple Syrup Urine Disease: Symptoms consistent include abnormal circulating lysine concentration and generalized hypotonia. Key symptoms not reported may include sweet-smelling urine and neurological decline. 
+4 Urea Cycle Disorder: Symptoms consistent include abnormal circulating lysine concentration and generalized hypotonia. Key symptoms not reported may include hyperammonemia and altered mental status. 
+5 Carnitine Transport Deficiency: Symptoms consistent include abnormal circulating carnitine concentration and generalized hypotonia. Key symptoms not reported may include muscle weakness and cardiomyopathy.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and developmental issues. Key symptoms not reported include intellectual disability and seizures. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and severe developmental issues. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include severe developmental issues and early mortality. Key symptoms not reported include specific metabolic derangements related to branched-chain amino acids. 
+4 Urea Cycle Disorders: Symptoms consistent include severe neurological damage and early death. Key symptoms not reported include hyperammonemia and specific metabolic crises. 
+5 Congenital Disorders of Glycosylation (CDG): Symptoms consistent include developmental delays and early mortality. Key symptoms not reported include specific glycosylation abnormalities and a broader range of systemic symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Congenital Cytomegalovirus Infection: This condition can lead to microcephaly, feeding difficulties, and developmental delays. Symptoms consistent with this diagnosis include microcephaly and small for gestational age. Key symptoms not reported include hearing loss and vision problems. 

+2 Phenylketonuria (PKU): This metabolic disorder is characterized by hyperphenylalaninemia due to phenylalanine hydroxylase deficiency. Symptoms consistent with this diagnosis include hyperphenylalaninemia and feeding difficulties. Key symptoms not reported include intellectual disability if untreated.

+3 Tyrosinemia: This condition is characterized by hypertyrosinemia and can lead to severe complications, including liver failure. Symptoms consistent with this diagnosis include hypertyrosinemia and feeding difficulties. Key symptoms not reported include liver dysfunction and renal issues.

+4 Congenital Syndromes (e.g., Down Syndrome, Turner Syndrome): These syndromes can present with microcephaly, short stature, and developmental delays. Symptoms consistent with this diagnosis include microcephaly and severe short stature. Key symptoms not reported include characteristic facial features or other specific anomalies.

+5 Congenital Heart Disease: The presence of pericardial and pleural effusions may suggest underlying congenital heart defects. Symptoms consistent with this diagnosis include pericardial effusion and feeding difficulties. Key symptoms not reported include cyanosis or other signs of heart failure.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine Transcarbamylase Deficiency: This condition is characterized by hyperammonemia, orotic aciduria, and can lead to severe neurological symptoms. The patient’s symptoms align well with this diagnosis. Key symptoms not reported include seizures or altered mental status during hyperammonemic episodes. 

+2 Carbamoyl Phosphate Synthetase I Deficiency: This disorder also leads to hyperammonemia and orotic aciduria. The symptoms are consistent with the patient's presentation. Key symptoms not reported may include lethargy or developmental delays.

+3 Argininosuccinate Synthetase Deficiency: This condition can present with hyperammonemia and may lead to orotic aciduria. The symptoms align with the patient's presentation. Key symptoms not reported include failure to thrive or developmental regression.

+4 Argininosuccinate Lyase Deficiency: This disorder can cause hyperammonemia and may present with orotic aciduria. The symptoms are consistent with the patient's presentation. Key symptoms not reported include irritability or feeding difficulties.

+5 Urea Cycle Disorder (unspecified): This is a broad category that includes various enzyme deficiencies leading to hyperammonemia and orotic aciduria. The symptoms align with the patient's presentation. Key symptoms not reported may include specific neurological deficits or metabolic crises.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia, abnormal circulating tyrosine concentration, and neonatal death. Key symptoms not reported include developmental delays and intellectual disability.
+2 Tyrosinemia: Symptoms consistent include abnormal circulating tyrosine concentration and elevated urinary carboxylic acid. Key symptoms not reported include liver dysfunction and renal issues.
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include elevated branched-chain amino acids. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms.
+4 Urea Cycle Disorders: Symptoms consistent include metabolic crises and potential neurological symptoms. Key symptoms not reported include hyperammonemia and lethargy.
+5 Alkaptonuria: Symptoms consistent include elevated urinary carboxylic acid. Key symptoms not reported include darkening of urine and joint pain.",Hereditary metabolic disorders
['Pearson syndrome'],"+1 Organic acidemia: This is supported by the presence of 3-methylglutaric aciduria and increased lactate and pyruvate levels. Key symptoms not reported include metabolic acidosis and specific neurological deficits.
+2 Mitochondrial disorder: The lethargy, coma, and elevated lactate and pyruvate levels are consistent with this diagnosis. Key symptoms not reported include myopathy or exercise intolerance.
+3 Cystic fibrosis: The exocrine pancreatic insufficiency and recurrent infections align with this condition. Key symptoms not reported include respiratory symptoms or failure to thrive in early infancy.
+4 Urea cycle disorder: The lethargy and coma could indicate hyperammonemia. Key symptoms not reported include vomiting and neurological symptoms related to ammonia toxicity.
+5 Fanconi syndrome: The renal Fanconi syndrome and electrolyte imbalances support this diagnosis. Key symptoms not reported include specific tubular dysfunction symptoms like phosphate wasting or rickets.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome: Symptoms consistent include broad and long philtrum, anteverted nares, syndactyly, hypocholesterolemia, and elevated 7-dehydrocholesterol. Key symptoms not reported include behavioral issues and possible cardiac defects. 
+2 Congenital Disorders of Glycosylation: Symptoms consistent include hypotonia and feeding difficulties. Key symptoms not reported include liver dysfunction and developmental delays. 
+3 Trisomy 18 (Edwards Syndrome): Symptoms consistent include hypotonia and facial dysmorphisms. Key symptoms not reported include clenched fists and severe developmental delays. 
+4 Cornelia de Lange Syndrome: Symptoms consistent include facial dysmorphisms and hypotonia. Key symptoms not reported include limb malformations and growth delays. 
+5 Meckel-Gruber Syndrome: Symptoms consistent include syndactyly and hypotonia. Key symptoms not reported include renal cysts and central nervous system malformations.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"+1 Severe Combined Immunodeficiency (SCID): Recurrent viral infections, history of death in childhood. Key symptoms not reported: Severe infections in infancy, failure to thrive. 
+2 Cystic Fibrosis: Vomiting, abdominal pain, recurrent infections. Key symptoms not reported: Chronic cough, difficulty gaining weight, salty skin. 
+3 Chronic Granulomatous Disease (CGD): Recurrent infections, abdominal pain. Key symptoms not reported: Granulomas, specific bacterial infections. 
+4 Hyper-IgM Syndrome: Recurrent infections, abdominal pain. Key symptoms not reported: Eczema, low immunoglobulin levels. 
+5 Wiskott-Aldrich Syndrome: Recurrent viral infections, history of death in childhood. Key symptoms not reported: Eczema, low platelet count.",Hereditary metabolic disorders
['Citrullinemia type I'],"+1 Urea Cycle Disorder: This includes conditions like Ornithine Transcarbamylase Deficiency. Symptoms consistent with this diagnosis include hyperammonemia, metabolic acidosis, and elevated citrulline. Key symptoms not reported may include neurological symptoms due to ammonia toxicity.
+2 Citrullinemia: Characterized by elevated citrulline and hyperammonemia. Symptoms consistent with this diagnosis include elevated plasma citrulline and metabolic acidosis. Key symptoms not reported may include lethargy or seizures.
+3 Argininosuccinic Aciduria: This condition could explain elevated arginine and citrulline levels. Symptoms consistent with this diagnosis include hyperammonemia and metabolic acidosis. Key symptoms not reported may include failure to thrive or developmental delays.
+4 Non-ketotic Hyperglycinemia: This condition could explain hyperglycinuria. Symptoms consistent with this diagnosis include metabolic disturbances. Key symptoms not reported may include hypotonia or seizures.
+5 Organic Acidemia: Conditions like Propionic Acidemia could present with metabolic acidosis. Symptoms consistent with this diagnosis include metabolic acidosis and elevated amino acids. Key symptoms not reported may include vomiting or lethargy.",Hereditary metabolic disorders
[],"+1 Methylmalonic Acidemia: This condition is characterized by elevated methylmalonic acid in the urine and plasma, which aligns with the patient's symptoms of lethargy, hypotonia, and metabolic derangements. Key symptoms not reported include failure to thrive and recurrent vomiting.

+2 Urea Cycle Disorder: The presence of hyperammonemia and lethargy suggests a possible urea cycle defect. Symptoms consistent with this diagnosis include drowsiness and dehydration. Key symptoms not reported include seizures and irritability.

+3 Homocystinuria: The hyperhomocystinemia indicates a potential for homocystinuria, which can cause developmental delays and lethargy. Symptoms consistent with this diagnosis include generalized hypotonia and sleep abnormalities. Key symptoms not reported include lens dislocation and thromboembolic events.

+4 Organic Acidemia: This is a broad category that includes conditions like propionic acidemia and isovaleric acidemia. The patient's metabolic profile suggests an organic acidemia, with symptoms of lethargy and hypotonia. Key symptoms not reported include metabolic acidosis and specific odor changes.

+5 Carnitine Deficiency: The decreased plasma free carnitine could indicate a primary carnitine deficiency, which can lead to lethargy and hypotonia. Symptoms consistent with this diagnosis include drowsiness and dehydration. Key symptoms not reported include muscle weakness and cardiomyopathy.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1 Urea Cycle Disorder: Hyperammonemia, hypotonia, and neurological symptoms. Key symptoms not reported include specific neurological deficits or seizures.
+2 Fatty Acid Oxidation Disorder: Decreased plasma free carnitine, hypotonia, and potential metabolic crisis. Key symptoms not reported include hypoglycemia or muscle pain during exertion.
+3 Maple Syrup Urine Disease: Abnormal circulating amino acid concentrations, particularly branched-chain amino acids. Key symptoms not reported include characteristic sweet-smelling urine and developmental delays.
+4 Organic Acidemia: Abnormal amino acid concentrations and hypotonia. Key symptoms not reported include metabolic acidosis or specific organic aciduria.
+5 Mitochondrial Disorder: Generalized hypotonia, hyperactivity, and potential metabolic derangements. Key symptoms not reported include exercise intolerance or multi-system involvement.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Congenital Heart Defect: Symptoms consistent include upper airway obstruction and death in infancy. Key symptoms not reported may include cyanosis or heart murmurs. 
+2 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and potential for neonatal death. Key symptoms not reported may include developmental delays or seizures. 
+3 Tyrosinemia: Symptoms consistent include hypertyrosinemia and potential for chronic pulmonary obstruction. Key symptoms not reported may include liver dysfunction or renal issues. 
+4 Congenital Airway Anomaly: Symptoms consistent include upper airway obstruction and death in infancy. Key symptoms not reported may include stridor or respiratory distress. 
+5 Smith-Lemli-Opitz Syndrome: Symptoms consistent include abnormality of prenatal development and potential for neonatal death. Key symptoms not reported may include dysmorphic features or developmental delays.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Metabolic Disorder (e.g., Medium-Chain Acyl-CoA Dehydrogenase Deficiency): Symptoms consistent include decreased plasma free carnitine, decreased 3-hydroxyacyl-CoA dehydrogenase level, and spasticity. Key symptoms not reported may include hypoglycemia and muscle weakness.

+2 Mitochondrial Myopathy: Symptoms consistent include spasticity, hypoxemia, and death in infancy/childhood. Key symptoms not reported may include exercise intolerance and muscle pain.

+3 Organic Acidemia (e.g., Propionic Acidemia): Symptoms consistent include neonatal death, hypoxemia, and metabolic derangements. Key symptoms not reported may include vomiting and metabolic acidosis.

+4 Iron-Deficiency Anemia: Symptoms consistent include decreased circulating ferritin concentration and possible hypoxemia. Key symptoms not reported may include fatigue and pallor.

+5 Vitamin B12 Deficiency: Symptoms consistent include abnormal circulating vitamin B12 concentration and potential neurological symptoms like spasticity. Key symptoms not reported may include macrocytic anemia and glossitis.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition explains the hypertyrosinemia and could account for the recurrent infections due to liver dysfunction. Key symptoms not reported include liver failure and neurological symptoms.
+2 Phenylketonuria (PKU): This explains the hyperphenylalaninemia. However, it typically does not lead to death if managed. Key symptoms not reported include developmental delays and intellectual disability.
+3 Urea Cycle Disorder: This could explain some metabolic derangements but does not specifically account for the combination of symptoms. Key symptoms not reported include hyperammonemia and neurological symptoms.
+4 Maple Syrup Urine Disease (MSUD): This condition could explain some metabolic issues but does not typically present with hyperphenylalaninemia. Key symptoms not reported include sweet-smelling urine and neurological symptoms.
+5 Combined Metabolic Disorder: This could explain the presence of both hypertyrosinemia and hyperphenylalaninemia, suggesting a more complex genetic issue. Key symptoms not reported include a broader range of metabolic derangements and potential organ dysfunction.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1 Non-ketotic hyperglycinemia (NKH): This condition is consistent with elevated glycine levels and aminoaciduria. Key symptoms not reported include neurological deficits and seizures. 
+2 Glycine encephalopathy: Similar to NKH, this condition aligns with the symptoms of elevated glycine and aminoaciduria. Key symptoms not reported include developmental delays and hypotonia. 
+3 Propionic acidemia: This diagnosis fits with elevated urinary carboxylic acids and aminoaciduria. Key symptoms not reported include metabolic acidosis and specific neurological symptoms. 
+4 Isovaleric acidemia: This condition is consistent with elevated urinary carboxylic acids. Key symptoms not reported include a characteristic odor and metabolic crises. 
+5 Maple syrup urine disease (MSUD): This diagnosis is less likely but could explain some aminoaciduria. Key symptoms not reported include a characteristic sweet odor and neurological symptoms.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1: Mitochondrial Disorder: Symptoms consistent include seizures, ataxia, motor delay, and hypotonia. Key symptoms not reported may include specific metabolic crises or myopathy.
+2: Lysosomal Storage Disorder: Symptoms consistent include hypotonia, developmental delays, and seizures. Key symptoms not reported may include organomegaly or specific neurological regression patterns.
+3: Urea Cycle Disorder: Symptoms consistent include elevated urinary carboxylic acid and neurological symptoms. Key symptoms not reported may include acute metabolic decompensation episodes.
+4: Neurodegenerative Disorder: Symptoms consistent include seizures, ataxia, and developmental delays. Key symptoms not reported may include progressive loss of skills or specific cognitive decline.
+5: Autism Spectrum Disorder: Symptoms consistent include delayed speech and hyperactivity. Key symptoms not reported may include social communication difficulties or repetitive behaviors.",Hereditary metabolic disorders
['Argininosuccinic aciduria'],"+1 Inborn Errors of Metabolism: Symptoms consistent include metabolic acidosis, vomiting, and hepatomegaly. Key symptoms not reported may include lethargy or seizures. 
+2 Sepsis: Symptoms consistent include tachycardia, metabolic acidosis, and tachypnea. Key symptoms not reported may include fever or hypotension. 
+3 Congenital Heart Disease: Symptoms consistent include tachycardia and metabolic acidosis. Key symptoms not reported may include cyanosis or failure to thrive. 
+4 Hepatic Failure: Symptoms consistent include hepatomegaly and metabolic acidosis. Key symptoms not reported may include jaundice or coagulopathy. 
+5 Respiratory Distress Syndrome: Symptoms consistent include tachypnea. Key symptoms not reported may include grunting or retractions.",Hereditary metabolic disorders
['Gyrate atrophy of choroid and retina'],"+1 Urea Cycle Disorder: Hyperammonemia, hypoargininemia, severe short stature, feeding difficulties. Key symptoms not reported: Neurological deficits, seizures. 
+2 Non-ketotic Hyperglycinemia: Hyperglycinemia, blindness, feeding difficulties. Key symptoms not reported: Neurological symptoms such as seizures or developmental delays. 
+3 Citrullinemia: Hyperammonemia, malabsorption, severe short stature. Key symptoms not reported: Elevated citrulline levels, specific neurological symptoms. 
+4 Argininosuccinic Aciduria: Hyperammonemia, feeding difficulties, severe short stature. Key symptoms not reported: Elevated argininosuccinic acid levels, specific neurological symptoms. 
+5 Mitochondrial Disorder: Anemia, malabsorption, severe short stature. Key symptoms not reported: Muscle weakness, exercise intolerance, specific metabolic derangements.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and can lead to severe outcomes, including neonatal death. Key symptoms not reported include liver dysfunction and renal issues. 
+2 Phenylketonuria (PKU): Aligns with hyperphenylalaninemia, but the absence of developmental delays makes it less likely. Key symptoms not reported include intellectual disability and seizures. 
+3 Maple Syrup Urine Disease (MSUD): While it presents with similar symptoms, it does not explain the specific amino acid abnormalities. Key symptoms not reported include characteristic sweet-smelling urine and neurological decline. 
+4 Urea Cycle Disorders: These can lead to severe neurological impairment and death but do not directly correlate with the reported amino acid abnormalities. Key symptoms not reported include hyperammonemia and lethargy. 
+5 Congenital Disorders of Glycosylation: Could account for a range of symptoms, but does not directly explain the specific amino acid issues. Key symptoms not reported include failure to thrive and developmental delays.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Urea Cycle Disorder: This condition is characterized by hyperammonemia, feeding difficulties, and hypotonia. Key symptoms not reported include seizures or altered consciousness during metabolic crises. 
+2 Organic Acidemia: This includes conditions like propionic acidemia, which can cause hypotonia, feeding difficulties, and metabolic crises leading to hyperammonemia. Key symptoms not reported may include metabolic acidosis or specific odor in urine. 
+3 Mitochondrial Disorder: These disorders can present with hypotonia and neurological symptoms, but hyperammonemia is less common. Key symptoms not reported include exercise intolerance or myopathy. 
+4 Peroxisomal Disorder: Conditions like X-linked adrenoleukodystrophy can cause hypotonia and neurological decline, but hyperammonemia is not typical. Key symptoms not reported include adrenal insufficiency or specific neurological deficits. 
+5 Severe Genetic Encephalopathy: Conditions such as non-ketotic hyperglycinemia could lead to hypotonia and neurological impairment, but would not typically present with hyperammonemia. Key symptoms not reported include lethargy or developmental delays.",Hereditary metabolic disorders
['Canavan disease'],"+1 Leigh syndrome: This mitochondrial disorder could explain the neurological symptoms, hypotonia, and seizures. Key symptoms not reported include progressive neurological decline.
+2 Metachromatic leukodystrophy: This condition could explain the abnormal myelination and neurological symptoms. Key symptoms not reported include progressive cognitive decline and behavioral changes.
+3 Aminoacidopathy: The abnormal amino acid concentrations suggest a metabolic disorder. Key symptoms not reported include specific metabolic crises or developmental delays.
+4 Congenital infections (e.g., TORCH complex): These can lead to a range of neurological symptoms. Key symptoms not reported include specific signs of infection or other systemic symptoms.
+5 Bardet-Biedl syndrome: This genetic disorder can cause blindness and hearing impairment. Key symptoms not reported include obesity and polydactyly, which are common in this syndrome.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Methylmalonic acidemia: Symptoms consistent include methylmalonic aciduria, intellectual disability, and dyskinesia. Key symptoms not reported may include metabolic crises or failure to thrive. 
+2 Congenital cytomegalovirus infection: Symptoms consistent include microcephaly, strabismus, and intellectual disability. Key symptoms not reported may include hearing loss or other organ involvement. 
+3 Smith-Lemli-Opitz syndrome: Symptoms consistent include microcephaly, strabismus, and developmental delays. Key symptoms not reported may include characteristic facial features or limb malformations. 
+4 Hydrocephalus due to congenital malformations: Symptoms consistent include hydrocephalus and intellectual disability. Key symptoms not reported may include specific congenital anomalies or signs of increased intracranial pressure. 
+5 Genetic syndromes (e.g., 22q11.2 deletion syndrome): Symptoms consistent include intellectual disability and developmental delays. Key symptoms not reported may include cardiac defects or specific facial dysmorphisms.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1: Fatty Acid Oxidation Disorder: Symptoms include decreased 3-hydroxyacyl-CoA dehydrogenase level, vomiting, and gastrointestinal inflammation. Key symptoms not reported include hypoglycemia and lethargy. 
+2: Organic Acidemia: Symptoms include vomiting and gastrointestinal inflammation, with potential links to abnormal carnitine levels. Key symptoms not reported include metabolic acidosis and failure to thrive. 
+3: Mitochondrial Disorder: Symptoms include abnormality of prenatal development and gastrointestinal issues. Key symptoms not reported include muscle weakness and neurological deficits. 
+4: Congenital Disorder of Glycosylation: Symptoms include abnormality of prenatal development and gastrointestinal symptoms. Key symptoms not reported include developmental delays and failure to thrive. 
+5: Inborn Error of Metabolism: Symptoms include vomiting and abnormal prenatal development. Key symptoms not reported include specific metabolic crises and developmental abnormalities.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Urea Cycle Disorder: This condition is consistent with hyperammonemia and hypotonia. Key symptoms not reported include seizures or neurological deficits.
+2 Organic Acidemia: Metabolic acidosis and hypotonia align with this diagnosis. Key symptoms not reported may include vomiting or failure to thrive.
+3 Mitochondrial Disorder: Hypotonia and metabolic acidosis are consistent, but hyperammonemia is less common. Key symptoms not reported could include developmental delays or seizures.
+4 Severe Combined Immunodeficiency (SCID): Leukopenia is a key symptom, but it does not explain hyperammonemia or metabolic acidosis. Key symptoms not reported include recurrent infections.
+5 Lysosomal Storage Disorder: Hypotonia is consistent, but the other symptoms do not typically align. Key symptoms not reported may include organomegaly or specific neurological symptoms.",Hereditary metabolic disorders
['Tyrosinemia type 2'],"+1 Tyrosinemia Type I: Symptoms include hypertyrosinemia, intellectual disability, seizures, and potential ocular symptoms. Key symptoms not reported include liver dysfunction and failure.

+2 Bardet-Biedl Syndrome: Symptoms include intellectual disability, photophobia, and potential renal issues. Key symptoms not reported include obesity and polydactyly.

+3 Cystinosis: Symptoms include photophobia and potential neurological involvement. Key symptoms not reported include renal failure and growth retardation.

+4 Galactosemia: Symptoms include intellectual disability and potential cataracts. Key symptoms not reported include jaundice and liver dysfunction.

+5 Mitochondrial disorders: Symptoms include neurological issues and photophobia. Key symptoms not reported include muscle weakness and exercise intolerance.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is consistent with hyperphenylalaninemia and could explain prenatal abnormalities. Key symptoms not reported include developmental delays if managed improperly. 
+2 Tyrosinemia: This fits with abnormal tyrosine levels and could explain the severe outcomes, including early death. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease (MSUD): This disorder aligns with abnormal amino acid levels and severe outcomes, particularly in infancy. Key symptoms not reported include neurological symptoms and distinctive urine odor. 
+4 Urea Cycle Disorders: These could explain severe outcomes and metabolic disturbances but do not specifically correlate with the amino acid abnormalities reported. Key symptoms not reported include hyperammonemia and neurological deficits. 
+5 Genetic syndromes (e.g., Smith-Lemli-Opitz syndrome): These could explain the combination of symptoms and early mortality. Key symptoms not reported include dysmorphic features and other systemic abnormalities.",Hereditary metabolic disorders
[],"+1 Urea Cycle Disorder: This condition is consistent with hyperammonemia, seizures, and the potential for neonatal death. Key symptoms not reported include lethargy and vomiting.
+2 Organic Acidemia: The presence of 3-hydroxydicarboxylic aciduria aligns with this diagnosis, along with seizures and metabolic crises. Key symptoms not reported may include metabolic acidosis and failure to thrive.
+3 Mitochondrial Disorder: This could explain seizures and cyanosis, but does not directly account for hyperammonemia. Key symptoms not reported include muscle weakness and exercise intolerance.
+4 Fatty Acid Oxidation Disorder: While seizures can occur, the hyperammonemia and specific aciduria suggest a different metabolic issue. Key symptoms not reported include hypoglycemia and cardiomyopathy.
+5 Cerebral Palsy or Other Neurological Disorders: Seizures are common, but the metabolic findings point more towards a metabolic cause. Key symptoms not reported include motor delays and spasticity.",Hereditary metabolic disorders
['Alkaptonuria'],"+1 Biliary Atresia: This condition can cause dark urine due to conjugated hyperbilirubinemia and vomiting. Key symptoms not reported include jaundice and abdominal distension. 
+2 Galactosemia: This metabolic disorder can lead to vomiting and dark urine due to liver dysfunction. Key symptoms not reported include failure to thrive and cataracts. 
+3 Tyrosinemia: This condition can present with vomiting and dark urine due to liver dysfunction. Key symptoms not reported include failure to thrive and neurological symptoms. 
+4 Inborn Errors of Metabolism: These can present with vomiting and altered urine color. Key symptoms not reported include lethargy and developmental delays. 
+5 Sepsis or Severe Infection: This can lead to vomiting and dark urine due to dehydration or liver involvement. Key symptoms not reported include fever and irritability.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, lethargy, seizures, and metabolic acidosis. Key symptoms not reported may include vomiting and irritability. 
+2 Maple Syrup Urine Disease (MSUD): Characterized by elevated branched-chain amino acids (valine, leucine, isoleucine), lethargy, feeding difficulties, and neurological symptoms. Key symptoms not reported may include a characteristic sweet odor in urine. 
+3 Organic Acidemia: Symptoms include metabolic acidosis, lethargy, and seizures. Key symptoms not reported may include vomiting and developmental delays. 
+4 Mitochondrial Disorder: Can present with seizures, lethargy, and growth delays. Key symptoms not reported may include muscle weakness and exercise intolerance. 
+5 Phenylketonuria (PKU): While primarily associated with elevated phenylalanine, it can present with developmental delays and neurological symptoms. Key symptoms not reported may include a musty odor in urine and skin rashes.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine Transcarbamylase (OTC) Deficiency: Symptoms include hyperammonemia, elevated plasma citrulline, orotic aciduria, and coma. Key symptoms not reported include specific neurological deficits that may arise from chronic hyperammonemia. 
+2 Argininosuccinate Synthetase Deficiency: Symptoms include hyperammonemia, elevated citrulline, and neurological symptoms. Key symptoms not reported include specific developmental delays or learning disabilities. 
+3 Argininosuccinate Lyase Deficiency: Symptoms include hyperammonemia, elevated arginine, and neurological symptoms. Key symptoms not reported include specific metabolic crises or failure to thrive. 
+4 Citrullinemia: Symptoms include hyperammonemia, elevated citrulline, and neurological symptoms. Key symptoms not reported include specific gastrointestinal symptoms or failure to thrive. 
+5 Mitochondrial Disorder: Symptoms include hypotonia, athetosis, and recurrent infections. Key symptoms not reported include specific mitochondrial myopathy or exercise intolerance.",Hereditary metabolic disorders
